Systematic review on the use of activated charcoal for gastrointestinal decontamination following acute oral overdose

References

• Holt LE, Jr., Holz PH. The black bottle. A consideration of the role of charcoal in the treatment of poisoning in children. J Pediatr. 1963;63:306–314.
   PubMed Web of Science ®Google Scholar
• Andersen AH. Experimental studies on the pharmacology of activated charcoal; adsorption power of charcoal in aqueous solutions. Acta Pharmacol Toxicol. 1946;2(1):69–78.
   PubMedGoogle Scholar
• Decker WJ, Corby DG, Ibanez JD. Jr. Aspirin adsorption with activated charcoal. Lancet. 1968;291(7545):754–755.
   Google Scholar
• Decker WJ, Shpall RA, Corby DG, et al. Inhibition of aspirin absorption by activated charcoal and apomorphine. Clin Pharmacol Ther. 1969;10(5):710–713.
   PubMed Web of Science ®Google Scholar
• Andersen HH. Medicinal charcoal in treatment of poisoning – treatment of experimental poisoning in pigs. Dan Med Bull. 1973;20(4):R20–R21.
   Google Scholar
• Atkinson JP, Azarnoff DL. Comparison of charcoal and attapulgite as gastrointestinal sequestrants in acute drug ingestions. Clin Toxicol. 1971;4(1):31–38.
   PubMed Web of Science ®Google Scholar
• Picchioni AL, Chin L, Laird HE. Activated charcoal preparations-relative antidotal efficacy. Clin Toxicol. 1974;7(1):97–108.
   PubMed Web of Science ®Google Scholar
• Picchioni AL, Consroe PF. Activated charcoal-a phencyclidine antidote, or hog in dogs. N Engl J Med. 1979;300(4):202.
   PubMed Web of Science ®Google Scholar
• Glab WN, Corby DG, Decker WJ, et al. Decreased absorption of propoxyphene by activated charcoal. J Toxicol Clin Toxicol. 1982;19(2):129–138.
   PubMed Web of Science ®Google Scholar
• Neuvonen PJ, Elfving SM, Elonen E. Reduction of absorption of digoxin, phenytoin and aspirin by activated charcoal in man. Eur J Clin Pharmacol. 1978;13(3):213–218.
   PubMed Web of Science ®Google Scholar
• Neuvonen PJ, Elonen E, Mattila MJ. Oral activated charcoal and dapsone elimination. Clin Pharmacol Ther. 1980;27(6):823–827.
   PubMed Web of Science ®Google Scholar
• Veltri JC, Litovitz TL. 1983 Annual report of the American association of poison control centers national data collection system. Am J Emerg Med. 1984;2(5):420–443.
   PubMed Web of Science ®Google Scholar
• Chyka PA, Seger D. Position statement: single-dose activated charcoal. American Academy of Clinical Toxicology; European Association of Poisons Centres and Clinical Toxicologists. J Toxicol Clin Toxicol. 1997;35(7):721–741.
   PubMedGoogle Scholar
• Vale JA, Krenzelok EP, Barceloux GD. Position statement and practice guidelines on the use of multi-dose activated charcoal in the treatment of acute poisoning. American Academy of Clinical Toxicology; European Association of Poisons Centres and Clinical Toxicologists. J Toxicol Clin Toxicol. 1999;37(6):731–751.
   PubMedGoogle Scholar
• Adams BK, Mann MD, Aboo A, et al. Prolonged gastric emptying half-time and gastric hypomotility after drug overdose. Am J Emerg Med. 2004;22(7):548–554.
   PubMed Web of Science ®Google Scholar
• Miyauchi MMD, Hayashida MP, Yokota HMD. Evaluation of residual toxic substances in the stomach using upper gastrointestinal endoscopy for management of patients with oral drug overdose on admission: a prospective, observational study. Medicine. 2015;94(4):e463.
   PubMed Web of Science ®Google Scholar
• Rauber-Luthy C, Hofer KE, Bodmer M, et al. Gastric pharmacobezoars in quetiapine extended-release overdose: a case series. Clin Toxicol. 2013;51(10):937–940.
   Web of Science ®Google Scholar
• Saetta JP, March S, Gaunt ME, et al. Gastric emptying procedures in the self-poisoned patient: are we forcing gastric content beyond the pylorus? J R Soc Med. 1991;84(5):274–276.
   PubMed Web of Science ®Google Scholar
• Saetta JP, Quinton DN. Residual gastric content after gastric lavage and ipecacuanha-induced emesis in self-poisoned patients: an endoscopic study. J R Soc Med. 1991;84(1):35–38.
   PubMed Web of Science ®Google Scholar
• Institute of Medicine Committee on Standards for Developing Trustworthy Clinical Practice Guidelines. In: Graham R, Mancher M, Miller Wolman D, et al., editors. Clinical practice guidelines we can trust. Washington (DC): National Academies Press (US) Copyright 2011 by the National Academy of Sciences; 2011.
   Google Scholar
• Bushnell PJ, Boyes WK, Shafer TJ, et al. Approaches to extrapolating animal toxicity data on organic solvents to public health. Neurotoxicology. 2007;28(2):221–226.
   PubMed Web of Science ®Google Scholar
• Whittemore AS, Grosser SC, Silvers A. Pharmacokinetics in low dose extrapolation using animal cancer data. Fundam Appl Toxicol. 1986;7(2):183–190.
   PubMedGoogle Scholar
• Committee on the Development of the Third Edition of the Reference Manual on Scientific Evidence; Committee on Science, Technology, and Law; National Research Council; Policy and Global Affairs; Federal Judicial Center. Reference manual on scientific evidence. 3rd ed. Washington (DC): National Academies Press; 2011.
   Google Scholar
• United States Food and Drug Administration. Animal Rule Information; 2002. Available from https://www.fda.gov/emergency-preparedness-and-response/mcm-regulatory-science/animal-rule-information
   Google Scholar
• Guyatt GH, Oxman AD, Kunz R, et al. GRADE guidelines: 6. Rating the quality of evidence-imprecision. J Clin Epidemiol. 2011;64(12):1283–1293.
   PubMed Web of Science ®Google Scholar
• Guyatt GH, Oxman AD, Kunz R, et al. GRADE guidelines: 8. Rating the quality of evidence-indirectness. J Clin Epidemiol. 2011;64(12):1303–1310.
   PubMed Web of Science ®Google Scholar
• Guyatt GH, Oxman AD, Kunz R, et al. GRADE guidelines: 7. Rating the quality of evidence-inconsistency. J Clin Epidemiol. 2011;64(12):1294–1302.
   PubMed Web of Science ®Google Scholar
• Guyatt GH, Oxman AD, Montori V, et al. GRADE guidelines: 5. Rating the quality of evidence-publication bias. J Clin Epidemiol. 2011;64(12):1277–1282.
   PubMed Web of Science ®Google Scholar
• Guyatt GH, Oxman AD, Sultan S, et al. GRADE guidelines: 9. Rating up the quality of evidence. J Clin Epidemiol. 2011;64(12):1311–1316.
   PubMed Web of Science ®Google Scholar
• Guyatt GH, Oxman AD, Vist G, et al. GRADE guidelines: 4. Rating the quality of evidence-study limitations (risk of bias). J Clin Epidemiol. 2011;64(4):407–415.
   PubMed Web of Science ®Google Scholar
• Chyka PA, Seger D, Krenzelok EP, et al. Position paper: single-dose activated charcoal. Clin Toxicol. 2005;43(2):61–87.
   PubMed Web of Science ®Google Scholar
• Bainbridge CA, Kelly EL, Walking WD. In vitro adsortpion of acetaminophen onto activated charcoal. J Pharm Sci. 1977;66(4):480–483.
   PubMed Web of Science ®Google Scholar
• Boehm JJ, Oppenheim RC. An in-vitro study of the adsorption of various drugs by activated charcoal. Australian J Pharm Sci. 1977;6(4):107–111.
   Google Scholar
• Al-Shareef AH, Buss DC, Routledge PA. Drug adsorption to charcoals and anionic binding resins. Hum Exp Toxicol. 1990;9(2):95–97.
   PubMed Web of Science ®Google Scholar
• Bailey DN, Coffee JJ, Anderson B, et al. Interaction of tricyclic antidepressants with cholestyramine in vitro. Ther Drug Monit. 1992;14(4):339–342.
   PubMed Web of Science ®Google Scholar
• Graudins A, Linden C. The effect of charcoal and drug concentrations on the adsorption of acetaminophen to activated charcoal. J Toxicol Clin Toxicol. 1996;34(5).
   Google Scholar
• Cassidy SL, Hale A, Buss DC, et al. In vitro drug adsorption to charcoal, silicas, acrylate copolymer and silicone oil with charcoal and with acrylate copolymer. Hum Exp Toxicol. 1997;16(1):25–27.
   PubMed Web of Science ®Google Scholar
• Walubo A, Madiba M, Mulahutso M, et al. A comparison of charcoal and cholestyramine dialysis of phenytoin and paracetamol in vitro. J Toxicol Clin Toxicol. 1998;36(5):436.
   Google Scholar
• Chock V, Yamamoto LG. In vitro acetaminophen adsorption by diatomaceous earth versus activated charcoal. Off Emerg Pediatr. 2000;13(1):21–24.
   Google Scholar
• Teubner DJO. Absence of ice-cream interference with the adsorption of paracetamol onto activated charcoal. Emerg Med Australas. 2000;12(4):326–328.
   Google Scholar
• Tenenbein PK, Sitar DS, Tenenbein M. Interaction between N-acetylcysteine and activated charcoal: implications for the treatment of acetaminophen poisoning. Pharmacotherapy. 2001;21(11):1331–1336.
   PubMed Web of Science ®Google Scholar
• Bailey DN, Briggs JR. The effect of ethanol and pH on the adsorption of drugs from simulated gastric fluid onto activated charcoal. Ther Drug Monit. 2003;25(3):310–313.
   PubMed Web of Science ®Google Scholar
• Hoegberg LC, Angelo HR, Christophersen AB, et al. Effect of ethanol and pH on the adsorption of acetaminophen (paracetamol) to high surface activated charcoal, in vitro studies. J Toxicol Clin Toxicol. 2002;40(1):59–67.
   PubMed Web of Science ®Google Scholar
• Hoegberg LC, Angelo HR, Christophersen AB, et al. The effect of food and ice cream on the adsorption capacity of paracetamol to high surface activated charcoal: in vitro studies. Pharmacol Toxicol. 2003;93(5):233–237.
   PubMedGoogle Scholar
• Hoegberg LCG, Christophersen AB, Christensen HR, et al. Comparison of the adsorption capacities of an activated-charcoal-yogurt mixture versus activated-charcoal-water slurry in vivo and in vitro. LCLT. 2005;43(4):269–275.
   Google Scholar
• Dargan PI, Melillo M, Wood DM, et al. In vitro studies with a novel granular activated charcoal. Clin Toxicol. 2006;44(5):686–687.
   Web of Science ®Google Scholar
• Yamamoto K, Onishi H, Ito A, et al. Medicinal carbon tablets for treatment of acetaminophen intoxication: adsorption characteristics of medicinal carbon powder and its tablets. Chem Pharm Bull. 2006;54(3):359–362.
   PubMed Web of Science ®Google Scholar
• Dasgupta A, Wells A. The effect of yogurt on acetaminophen absorption by activated charcoal and burnt toast. J Clin Lab Anal. 2007;21(6):393–397.
   PubMed Web of Science ®Google Scholar
• Yamamoto K, Onishi H, Ito A, et al. In vitro and in vivo evaluation of medicinal carbon granules and tablet on the adsorption of acetaminophen. Int J Pharm. 2007;328(2):105–111.
   PubMed Web of Science ®Google Scholar
• Miyachi M, Onishi H, Yumoto T, et al. Preparation of medicinal carbon tablets by modified wet compression method. Drug Dev Ind Pharm. 2009;35(11):1333–1338.
   PubMed Web of Science ®Google Scholar
• Hoegberg LCG, Groenlykke TB, Abildtrup U, et al. Combined paracetamol and amitriptyline adsorption to activated charcoal. Clin Toxicol. 2010;48(9):898–903.
   Web of Science ®Google Scholar
• Wilson HE, Humm KR. In vitro study of the effect of dog food on the adsorptive capacity of activated charcoal. J Vet Emerg Crit Care. 2013;23(3):263–267.
   PubMed Web of Science ®Google Scholar
• Spiller HA, Sawyer TS. Impact of activated charcoal after acute acetaminophen overdoses treated with N-acetylcysteine. J Emerg Med. 2007;33(2):141–144.
   PubMed Web of Science ®Google Scholar
• Buckley NA, Whyte IM, O'Connell DL, et al. Activated charcoal reduces the need for N-acetylcysteine treatment after acetaminophen (paracetamol) overdose. J Toxicol Clin Toxicol. 1999;37(6):753–757.
   PubMed Web of Science ®Google Scholar
• Chiew AL, Isbister GK, Kirby KA, et al. Massive paracetamol overdose: an observational study of the effect of activated charcoal and increased acetylcysteine dose (ATOM-2). Clin Toxicol. 2017;55(10):1055–1065.
   PubMed Web of Science ®Google Scholar
• Dordoni B, Willson RA, Thompson RP, et al. Reduction of absorption of paracetamol by activated charcoal and cholestyramine: a possible therapeutic measure. Br Med J. 1973;3(5871):86–87.
   PubMedGoogle Scholar
• Levy G, Houston JB. Effect of activated charcoal on acetaminophen absorption. Pediatrics. 1976;58(3):432–435.
   PubMed Web of Science ®Google Scholar
• Mathur LK, Jaffe JM, Colaizzi JL. Charcoal and acetaminophen toxicity. Drug Intell Clin Pharm. 1977;11(6):368–368.
   Google Scholar
• Neuvonen PJ, Vartiainen M, Tokola O. Comparison of activated charcoal and ipecac syrup in prevention of drug absorption. Eur J Clin Pharmacol. 1983;24(4):557–562.
   PubMed Web of Science ®Google Scholar
• Galinsky RE, Levy G. Evaluation of activated charcoal-sodium sulfate combination for inhibition of acetaminophen absorption and repletion of inorganic sulfate. J Toxicol Clin Toxicol. 1984;22(1):21–30.
   PubMed Web of Science ®Google Scholar
• McNamara RM, Aaron CK, Gemborys M, et al. Sorbitol catharsis does not enhance efficacy of charcoal in a simulated acetaminophen overdose. Ann Emerg Med. 1988;17(3):243–246.
   PubMed Web of Science ®Google Scholar
• McNamara RM, Aaron CK, Gemborys M, et al. Efficacy of charcoal cathartic versus ipecac in reducing serum acetaminophen in a simulated overdose. Ann Emerg Med. 1989;18(9):934–938.
   PubMed Web of Science ®Google Scholar
• Remmert HP, Olling M, Slob W, et al. Comparative antidotal efficacy of activated charcoal tablets, capsules and suspension in healthy volunteers. Eur J Clin Pharmacol. 1990;39(5):501–505.
   PubMed Web of Science ®Google Scholar
• Rose SR, Gorman RL, Oderda GM, et al. Simulated acetaminophen overdose pharmacokinetics and effectiveness of activated charcoal. Ann Emerg Med. 1991;20(10):1064–1068.
   PubMed Web of Science ®Google Scholar
• Roberts J, Gracely E, Schoffstall J. Advantage of high-surface-area charcoal for gastrointestinal decontamination in a human acetaminophen ingestion model. Acad Emerg Med. 1997;4(3):167–174.
   PubMed Web of Science ®Google Scholar
• Yeates PJ, Thomas SH. Effectiveness of delayed activated charcoal administration in simulated paracetamol (acetaminophen) overdose. Br J Clin Pharmacol. 2000;49(1):11–14.
   PubMed Web of Science ®Google Scholar
• Green R, Grierson R, Sitar DS, et al. How long after drug ingestion is activated charcoal still effective? J Toxicol Clin Toxicol. 2001;39(6):601–605.
   PubMed Web of Science ®Google Scholar
• Rangan C, Nordt SP, Hamilton R, et al. Treatment of acetaminophen ingestion with a superactivated charcoal-cola mixture. Ann Emerg Med. 2001;37(1):55–58.
   PubMed Web of Science ®Google Scholar
• Christophersen AB, Levin D, Hoegberg LC, et al. Activated charcoal alone or after gastric lavage: a simulated large paracetamol intoxication. Br J Clin Pharmacol. 2002;53(3):312–317.
   PubMed Web of Science ®Google Scholar
• Sato RL, Wong JJ, Sumida SM, et al. Efficacy of superactivated charcoal administered late (3 hours) after acetaminophen overdose. Am J Emerg Med. 2003;21(3):189–191.
   PubMed Web of Science ®Google Scholar
• Green R, Sitar DS, Tenenbein M. Effect of anticholinergic drugs on the efficacy of activated charcoal. J Toxicol Clin Toxicol. 2004;42(3):267–272.
   PubMed Web of Science ®Google Scholar
• Mullins M, Froelke BR, Rivera MR-P. Effect of delayed activated charcoal on acetaminophen concentration after simulated overdose of oxycodone and acetaminophen. Clin Toxicol. 2009;47(2):112–115.
   Web of Science ®Google Scholar
• Wananukul W, Klaikleun S, Sriapha C, et al. Effect of activated charcoal in reducing paracetamol absorption at a supra-therapeutic dose. Chotmaihet Thangphaet [J Medical Ass Thailand]. 2010;93(10):1145–1149.
   PubMedGoogle Scholar
• Underhill TJ, Greene MK, Dove AF. A comparison of the efficacy of gastric lavage, ipecacuanha and activated charcoal in the emergency management of paracetamol overdose. Arch Emerg Med. 1990;7(3):148–154.
   PubMedGoogle Scholar
• Gude AB, Hoegberg LC, Angelo HR, et al. Dose-dependent adsorptive capacity of activated charcoal for gastrointestinal decontamination of a simulated paracetamol overdose in human volunteers. Basic Clin Pharmacol Toxicol. 2010;106(5):406–410.
   PubMed Web of Science ®Google Scholar
• Friberg LE, Isbister GK, Duffull SB. Pharmacokinetic-pharmacodynamic modelling of QT interval prolongation following citalopram overdoses. Br J Clin Pharmacol. 2006;61(2):177–190.
   PubMed Web of Science ®Google Scholar
• van Gorp F, Duffull S, Hackett LP, et al. Population pharmacokinetics and pharmacodynamics of escitalopram in overdose and the effect of activated charcoal. Br J Clin Pharmacol. 2012;73(3):402–410.
   PubMed Web of Science ®Google Scholar
• Isbister GK, Friberg LE, Hackett LP, et al. Pharmacokinetics of quetiapine in overdose and the effect of activated charcoal. Clin Pharmacol Ther. 2007;81(6):821–827.
   PubMed Web of Science ®Google Scholar
• Isbister GK, Duffull SB. Quetiapine overdose: predicting intubation, duration of ventilation, cardiac monitoring and the effect of activated charcoal. Int Clin Psychopharmacol. 2009;24(4):174–180.
   PubMed Web of Science ®Google Scholar
• Alkhamis KA, Wurster DE. Prediction of adsorption from multicomponent solutions by activated carbon using single-solute parameters. Part II-proposed equation. AAPS PharmSciTech. 2002;3(3):E23.
   PubMedGoogle Scholar
• Alkhamis KA, Wurster DE. Study of multiple-component adsorption on the surface of activated carbon using a model system of benzyl alcohol and phenobarbital. Pharm Dev Technol. 2003;8(2):127–133.
   PubMed Web of Science ®Google Scholar
• Burke GM, Wurster DE, Buraphacheep V, et al. Model selection for the adsorption of phenobarbital by activated charcoal. Pharm Res. 1991;8(2):228–231.
   PubMed Web of Science ®Google Scholar
• Cooney DO. In vitro adsorption of phenobarbital, chlorpheniramine maleate, and theophylline by four commercially available activated charcoal suspensions. J Toxicol Clin Toxicol. 1995;33(3):213–217.
   PubMed Web of Science ®Google Scholar
• Edwards KD, McCredie M. Studies on the binding properties of acidic, basic and neutral drugs to anion and cation exchange resins and charcoal in vitro. Med J Aust. 1967;1(11):534–539.
   PubMedGoogle Scholar
• Honda Y, Nakano M, Nakano NI. Prevention of gastrointestinal absorption of phenobarbital by activated carbon beads as an oral adsorbent. J Pharmacobiodyn. 1990;13(10):597–601.
   PubMedGoogle Scholar
• Javaid KA, El-Mabrouk BH. In vitro adsorption of phenobarbital onto activated charcoal. J Pharm Sci. 1983;72(1):82–85.
   PubMed Web of Science ®Google Scholar
• McElnay JC, Sidahmed AM, D'Arcy PF. Experimental modeling of drug absorption and drug absorption interactions. Int J Pharm. 1986;31(1-2):107–118.
   Google Scholar
• Sellers EM, Khouw V, Dolman L. Comparative drug adsorption by activated charcoal. J Pharm Sci. 1977;66(11):1640–1641.
   PubMed Web of Science ®Google Scholar
• Wurster DE, Alkhamis KA, Matheson LE. Prediction of adsorption from multicomponent solutions by activated carbon using single-solute parameters. AAPS PharmSciTech. 2000;1(3):E25.
   PubMedGoogle Scholar
• Wurster DE, Burke GM, Berg MJ, et al. Phenobarbital adsorption from simulated intestinal fluid, U.S.P., and simulated gastric fluid, U.S.P., by two activated charcoals. Pharm Res. 1988;5(3):183–186.
   PubMed Web of Science ®Google Scholar
• Smith RP, Gosselin RE, Henderson JA, et al. Comparison of the adsorptive properties of activated charcoal and alaskan montmorillonite for some common poison. Toxicol Appl Pharmacol. 1967;10(1):95–104.
   PubMed Web of Science ®Google Scholar
• Chin L, Picchioni AL, Duplisse BR. The action of activated charcoal on poisons in the digestive tract. Toxicol Appl Pharmacol. 1970;16(3):786–799.
   PubMed Web of Science ®Google Scholar
• Cooney DO, Kane RP. “Superactive” charcoal adsorbs drugs as fast as standard antidotal charcoal. Clin Toxicol. 1980;16(1):123–125.
   PubMed Web of Science ®Google Scholar
• Curd-Sneed CD, McNatt LE, Stewart JJ. Absorption of sodium pentobarbital by three types of activated charcoal. Vet Hum Toxicol. 1986;28(6):524–526.
   PubMedGoogle Scholar
• Curd-Sneed CD, Bordelon JG, Parks KS, et al. Effects of activated charcoal and sorbitol on sodium pentobarbital absorption in the rat. J Toxicol Clin Toxicol. 1987;25(7):555–566.
   PubMed Web of Science ®Google Scholar
• Modi NB, Veng-Pedersen P, Wurster DE, et al. Phenobarbital removal characteristics of three brands of activated charcoals: a system analysis approach. Pharm Res. 1994;11(2):318–323.
   PubMed Web of Science ®Google Scholar
• Neuvonen PJ, Elonen E. Phenobarbitone elimination rate after oral charcoal. Br Med J. 1980;280(6216):762.
   PubMedGoogle Scholar
• Pond SM, Olson KR, Osterloh JD, et al. Randomized study of the treatment of phenobarbital overdose with repeated doses of activated charcoal. JAMA. 1984;251(23):3104–3108.
   PubMed Web of Science ®Google Scholar
• Berg MJ, Berlinger WG, Goldberg MJ, et al. Acceleration of the body clearance of phenobarbital by oral activated charcoal. N Engl J Med. 1982;307(11):642–644.
   PubMed Web of Science ®Google Scholar
• Gillespie WR, Veng-Pedersen P, Berg MJ, et al. Linear systems approach to the analysis of an induced drug removal process. Phenobarbital removal by oral activated charcoal. J Pharmacokinet Biopharm. 1986;14(1):19–28.
   PubMedGoogle Scholar
• Berg MJ, Rose JQ, Wurster DE, et al. Effect of charcoal and sorbitol-charcoal suspension on the elimination of intravenous phenobarbital. Ther Drug Monit. 1987;9(1):41–47.
   PubMed Web of Science ®Google Scholar
• Frenia ML, Schauben JL, Wears RL, et al. Multiple-dose activated charcoal compared to urinary alkalinization for the enhancement of phenobarbital elimination. J Toxicol Clin Toxicol. 1996;34(2):169–175.
   PubMed Web of Science ®Google Scholar
• Stoykova M, Koumanova B, Mörl L. Adsorptive removal of carbamazepine from wastewaters by activated charcoals. J Chem Technol Metall. 2013;48(5):469–474.
   Google Scholar
• Lapatto-Reiniluoto O, Kivistö KT, Neuvonen PJ. Activated charcoal alone and followed by whole-bowel irrigation in preventing the absorption of sustained-release drugs. Clin Pharmacol Ther. 2001;70(3):255–260.
   PubMed Web of Science ®Google Scholar
• Neuvonen PJ, Kivisto K, Hirvisalo EL. Effects of resins and activated charcoal on the absorption of digoxin, carbamazepine and frusemide. Br J Clin Pharmacol. 1988;25(2):229–233.
   PubMed Web of Science ®Google Scholar
• Brahmi N, Kouraichi N, Thabet H, et al. Influence of activated charcoal on the pharmacokinetics and the clinical features of carbamazepine poisoning. Am J Emerg Med. 2006;24(4):440–443.
   PubMed Web of Science ®Google Scholar
• Risler T, Somberg JC, Smith TW. Renal elimination of digoxin: studies with tritiated digoxin and radioimmunoassay. J Pharmacol Exp Ther. 1981;218(2):368–374.
   PubMed Web of Science ®Google Scholar
• Park GD, Goldberg MJ, Spector R, et al. The effects of activated charcoal on digoxin and digitoxin clearance. Drug Intell Clin Pharm. 1985;19(12):937–941.
   PubMedGoogle Scholar
• Lalonde RL, Deshpande R, Hamilton PP, et al. Acceleration of digoxin clearance by activated charcoal. Clin Pharmacol Ther. 1985;37(4):367–371.
   PubMed Web of Science ®Google Scholar
• Dasgupta A, Cao S, Wells A. Activated charcoal is effective but equilibrium dialysis is ineffective in removing oleander leaf extract and oleandrin from human serum: monitoring the effect by measuring apparent digoxin concentration. Ther Drug Monit. 2003;25(3):323–330.
   PubMed Web of Science ®Google Scholar
• Tiwary AK, Poppenga RH, Puschner B. In vitro study of the effectiveness of three commercial adsorbents for binding oleander toxins. Clin Toxicol. 2009;47(3):213–218.
   Web of Science ®Google Scholar
• Eddleston M, Juszczak E, Buckley NA, et al. Multiple-dose activated charcoal in acute self-poisoning: a randomised controlled trial. Lancet. 2008;371(9612):579–587.
   PubMed Web of Science ®Google Scholar
• de Silva HA, Fonseka MM, Pathmeswaran A, et al. Multiple-dose activated charcoal for treatment of yellow oleander poisoning: a single-blind, randomised, placebo-controlled trial. Lancet. 2003;361(9373):1935–1938.
   PubMed Web of Science ®Google Scholar
• Mohamed F, Sooriyarachchi MR, Senarathna L, et al. Compliance for single and multiple dose regimens of superactivated charcoal: a prospective study of patients in a clinical trial. Clin Toxicol. 2007;45(2):132–135.
   Web of Science ®Google Scholar
• Roberts DM, Southcott E, Potter JM, et al. Pharmacokinetics of digoxin cross-reacting substances in patients with acute yellow oleander (Thevetia peruviana) poisoning, including the effect of activated charcoal. Ther Drug Monit. 2006;28(6):784–792.
   PubMed Web of Science ®Google Scholar
• Wang X, Mondal S, Wang J, et al. Effect of activated charcoal on apixaban pharmacokinetics in healthy subjects. Am J Cardiovasc Drugs. 2014;14(2):147–154.
   PubMed Web of Science ®Google Scholar
• Ollier E, Hodin S, Lanoiselee J, et al. Effect of activated charcoal on rivaroxaban complex absorption. Clin Pharmacokinet. 2017;56(7):793–801.
   PubMed Web of Science ®Google Scholar
• Hultén BA, Heath A, Mellstrand T, et al. Does alcohol absorb to activated charcoal? Hum Toxicol. 1986;5(3):211–212.
   PubMedGoogle Scholar
• Chyka PA, Butler AY, Herman MI. Ferrous sulfate adsorption by activated charcoal. Vet Hum Toxicol. 2001;43(1):11–13.
   PubMedGoogle Scholar
• Gomez HF, McClafferty HH, Flory D, et al. Prevention of gastrointestinal iron absorption by chelation from an orally administered premixed deferoxamine/charcoal slurry. Ann Emerg Med. 1997;30(5):587–592.
   PubMed Web of Science ®Google Scholar
• Phansalkar SV, Holt LE. Jr. Observations on the immediate treatment of poisoning. J Pediatr. 1968;72(5):682–685.
   PubMed Web of Science ®Google Scholar
• Tsuchiya T, Levy G. Relationship between effect of activated charcoal on drug absorption in man and its drug adsorption characteristics in vitro. J Pharm Sci. 1972;61(4):586–589.
   PubMed Web of Science ®Google Scholar
• Daly JS, Cooney DO. Interference by tannic acid with the effectiveness of activated charcoal in "universal antidote. Clin Toxicol. 1978;12(5):515–522.
   PubMed Web of Science ®Google Scholar
• Daly JS, Cooney DO. Omission of pepsin from simulated gastric fluid in evaluating activated charcoals as antidotes. J Pharm Sci. 1978;67(8):1181–1183.
   PubMed Web of Science ®Google Scholar
• Scholtz EC, Jaffe JM, Colaizzi JL. Evaluation of five activated charcoal formulations for inhibition of aspirin absorption and palatability in man. Am J Hosp Pharm. 1978;35(11):1355–1359.
   PubMedGoogle Scholar
• Dawling S, Chand S, Braithwaite RA, et al. In vitro and in vivo evaluation of two preparations of activated charcoal as adsorbents of aspirin. Hum Toxicol. 1983;2(2):211–216.
   PubMedGoogle Scholar
• Neuvonen PJ, Olkkola KT, Alanen T. Effect of ethanol and pH on the adsorption of drugs to activated charcoal: studies in vitro and in man. Acta Pharmacol Toxicol. 1984;54(1):1–7.
   PubMedGoogle Scholar
• Olkkola KT, Neuvonen PJ. Effect of gastric pH on antidotal efficacy of activated charcoal in man. Int J Clin Pharmacol Ther Toxicol. 1984;22(10):565–569.
   PubMedGoogle Scholar
• Olkkola KT. Effect of charcoal-drug ratio on antidotal efficacy of oral activated charcoal in man. Br J Clin Pharmacol. 1985;19(6):767–773.
   PubMed Web of Science ®Google Scholar
• Cooney DO, Wijaya J. Effect of magnesium citrate on the adsorptive capacity of activated charcoal for sodium salicylate. Vet Hum Toxicol. 1986;28(6):521–523.
   PubMedGoogle Scholar
• Okore VC. Interaction of sodium salicylate with starch: the basis for the use of starch in the management of acute salicylate poisoning. STP Pharma Sci. 1994;4(5):373–376.
   Google Scholar
• Tschen T, Miller S, Zilberman H, et al. Effects of vehicle on the efficacy of activated charcoal. Clin Pharmacol Ther. 1999;65(2):137–137.
   Web of Science ®Google Scholar
• Czajka PA, Konrad JD. Saline cathartics and the adsorptive capacity of activated charcoal for aspirin. Ann Emerg Med. 1986;15(5):548–551.
   PubMed Web of Science ®Google Scholar
• Mathur LK, Jaffe JM, Colaizzi JL, et al. Activated charcoal carboxymethylcellulose gel formulation as an antidotal agent for orally ingested aspirin. Am J Hosp Pharm. 1976;33(7):717–719.
   PubMedGoogle Scholar
• Mayersohn M, Perrier D, Picchioni AL. Evaluation of a charcoal-sorbitol mixture as an antidote for oral aspirin overdose. Clin Toxicol. 1977;11(5):561–567.
   PubMed Web of Science ®Google Scholar
• Juhl RP. Comparison of kaolin-pectin and activated charcoal for inhibition of aspirin absorption. Am J Hosp Pharm. 1979;36(8):1097–1098.
   PubMedGoogle Scholar
• Navarro RP, Navarro KR, Krenzelok EP. Relative efficacy and palatability of three activated charcoal mixtures. Vet Hum Toxicol. 1980;22(1):6–9.
   PubMedGoogle Scholar
• Chung DC, Murphy JE, Taylor TW. In-vivo comparison of the adsorption capacity of "superactive charcoal" and fructose with activated charcoal and fructose. J Toxicol Clin Toxicol. 1982;19(2):219–224.
   PubMed Web of Science ®Google Scholar
• Easom JM, Caraccio TR, Lovejoy FH. Jr. Evaluation of activated charcoal and magnesium citrate in the prevention of aspirin absorption in humans. Clin Pharm. 1982;1(2):154–156.
   PubMedGoogle Scholar
• Sketris IS, Mowry JB, Czajka PA, et al. Saline catharsis: effect on aspirin bioavailability in combination with activated charcoal. J Clin Pharmacol. 1982;22(1):59–64.
   PubMed Web of Science ®Google Scholar
• Curtis RA, Barone J, Giacona N. Efficacy of ipecac and activated charcoal/cathartic. Prevention of salicylate absorption in a simulated overdose. Arch Intern Med. 1984;144(1):48–52.
   PubMedGoogle Scholar
• Olkkola KT, Neuvonen PJ. Do gastric contents modify antidotal efficacy of oral activated charcoal? Br J Clin Pharmacol. 1984;18(5):663–669.
   PubMed Web of Science ®Google Scholar
• Barone JA, Raia JJJ, Deeter RG. Effect of multiple dose activated charcoal Ac on aspirin asa absorption. Clin Pharmacol Ther. 1987;41(2):155–248.
   PubMed Web of Science ®Google Scholar
• Filippone GA, Fish SS, Lacouture PG, et al. Reversible adsorption (desorption) of aspirin from activated charcoal. Arch Intern Med. 1987;147(8):1390–1392.
   PubMedGoogle Scholar
• Krenzelok EP, Heller MB. Effectiveness of commercially available aqueous activated charcoal products. Ann Emerg Med. 1987;16(12):1340–1343.
   PubMed Web of Science ®Google Scholar
• Barone JA, Raia JJ, Huang YC. Evaluation of the effects of multiple-dose activated charcoal on the absorption of orally administered salicylate in a simulated toxic ingestion model. Ann Emerg Med. 1988;17(1):34–37.
   PubMed Web of Science ®Google Scholar
• Danel V, Henry JA, Glucksman E. Activated charcoal, emesis, and gastric lavage in aspirin overdose. Br Med J (Clin Res Ed). 1988;296(6635):1507–1507.
   PubMedGoogle Scholar
• Rosenberg PJ, Livingstone DJ, McLellan BA. Effect of whole-bowel irrigation on the antidotal efficacy of oral activated charcoal. Ann Emerg Med. 1988;17(7):681–683.
   PubMed Web of Science ®Google Scholar
• Dillon EC, Jr., Wilton JH, Barlow JC, et al. Large surface area activated charcoal and the inhibition of aspirin absorption. Ann Emerg Med. 1989;18(5):547–552.
   PubMed Web of Science ®Google Scholar
• Kirshenbaum LA, Mathews SC, Sitar DS, et al. Whole-bowel irrigation versus activated charcoal in sorbitol for the ingestion of modified-release pharmaceuticals. Clin Pharmacol Ther. 1989;46(3):264–271.
   PubMed Web of Science ®Google Scholar
• Eisen TF, Grbcich PA, Lacouture PG, et al. The adsorption of salicylates by a milk chocolate-charcoal mixture. Ann Emerg Med. 1991;20(2):143–146.
   PubMed Web of Science ®Google Scholar
• Hale AL, Harry FM, Williams AP, et al. The effect of addition of ice cream to charcoal on the pharmacokinetics of aspirin. Hum Exp Toxicol. 1998;17(1):58.
   Google Scholar
• Bansal A, Barone JA, Woodward DK. Effect of activated charcoal temperature in simulated overdose. Pharmacotherapy. 2005;25(3):475.
   Web of Science ®Google Scholar
• Comstock EG, Boisaubin EV, Comstock BS, et al. Assessment of the efficacy of activated charcoal following gastric lavage in acute drug emergencies. J Toxicol Clin Toxicol. 1982;19(2):149–165.
   PubMed Web of Science ®Google Scholar
• Ho JL, Tierney MG, Dickinson GE. An evaluation of the effect of repeated doses of oral activated charcoal on salicylate elimination. J Clin Pharmacol. 1989;29(4):366–369.
   PubMed Web of Science ®Google Scholar
• Kirshenbaum LA, Mathews SC, Sitar DS, et al. Does multiple-dose charcoal therapy enhance salicylate excretion? Arch Intern Med. 1990;150(6):1281–1283.
   PubMedGoogle Scholar
• Mayer AL, Sitar DS, Tenenbein M. Multiple-dose charcoal and whole-bowel irrigation do not increase clearance of absorbed salicylate. Arch Intern Med. 1992;152(2):393–396.
   PubMedGoogle Scholar
• Ruskosky D, Schauben J, Kunisaki T. Urinary alkalinization compared to multidose activated charcoal for the enhancement of salicylate elimination. J Toxicol Clin Toxicol. 1998;36(5):446.
   Google Scholar
• Helliwell M, Berry D. Theophylline absorption by effervescent activated charcoal (medicoal). J Int Med Res. 1981;9(3):222–225.
   PubMed Web of Science ®Google Scholar
• Sintek C, Hendeles L, Weinberger M. Activated charcoal adsorption of theophylline in vitro. Drug Intell Clin Pharm. 1978;12(3):158–160.
   Google Scholar
• Hoffman RS, Chiang WK, Howland MA, et al. Drug desorption from activated charcoal caused by whole bowel irrigation solution. Vet Hum Toxicol. 1989;31(4).
   PubMedGoogle Scholar
• Lim DT, Singh P, Nourtsis S, et al. Absorption inhibition and enhancement of elimination of sustained-release theophylline tablets by oral activated charcoal. Ann Emerg Med. 1986;15(11):1303–1307.
   PubMed Web of Science ®Google Scholar
• Sintek C, Hendeles L, Weinberger M. Inhibition of theophylline absorption by activated charcoal. J Pediatr. 1979;94(2):314–316.
   PubMed Web of Science ®Google Scholar
• Al-Shareef AH, Buss DC, Allen EM, et al. The effects of charcoal and sorbitol (alone and in combination) on plasma theophylline concentrations after a sustained-release formulation. Hum Exp Toxicol. 1990;9(3):179–182.
   PubMed Web of Science ®Google Scholar
• Berlinger WG, Spector R, Goldberg MJ, et al. Enhancement of theophylline clearance by oral activated charcoal. Clin Pharmacol Ther. 1983;33(3):351–354.
   PubMed Web of Science ®Google Scholar
• Ginoza GW, Strauss AA, Iskra MK, et al. Potential treatment of theophylline toxicity by high surface area activated charcoal. J Pediatr. 1987;111(1):140–142.
   PubMed Web of Science ®Google Scholar
• Goldberg MJ, Spector R, Park GD, et al. The effect of sorbitol and activated charcoal on serum theophylline concentrations after slow-release theophylline. Clin Pharmacol Ther. 1987;41(1):108–111.
   PubMed Web of Science ®Google Scholar
• Ilkhanipour K, Yealy DM, Krenzelok EP. The comparative efficacy of various multiple-dose activated charcoal regimens. Am J Emerg Med. 1992;10(4):298–300.
   PubMed Web of Science ®Google Scholar
• Ilkhanipour K, Yealy DM, Krenzelok EP. Activated charcoal surface area and its role in multiple-dose charcoal therapy. Am J Emerg Med. 1993;11(6):583–585.
   PubMed Web of Science ®Google Scholar
• Mahutte CK, True RJ, Michiels TM, et al. Increased serum theophylline clearance with orally administered activated charcoal. Am Rev Respir Dis. 1983;128(5):820–822.
   PubMedGoogle Scholar
• Minton NA, Glucksman E, Henry JA. Prevention of drug absorption in simulated theophylline overdose. Hum Exp Toxicol. 1995;14(2):170–174.
   PubMed Web of Science ®Google Scholar
• Minton NA, Henry JA, Rolls LJ, et al. Prevention of drug absorption following simulated overdose of sustained-release theophylline. Br J Clin Pharmacol. 1990;29(5):605P–606P.
   Web of Science ®Google Scholar
• Park GD, Radomski L, Goldberg MJ, et al. Effects of size and frequency of oral doses of charcoal on theophylline clearance. Clin Pharmacol Ther. 1983;34(5):663–666.
   PubMed Web of Science ®Google Scholar
• Reed RC, Zawadski D, Salazar R, et al. Influence of food on the ability of charcoal to enhance theophylline elimination. Clin Pharmacol Ther. 1988;43(2):147.
   Web of Science ®Google Scholar
• Crome P, Dawling S, Braithwaite RA, et al. Effect of activated charcoal on absorption of nortriptyline. Lancet. 1977;2(8050):1203–1205.
   PubMed Web of Science ®Google Scholar
• Valente Nabais JM, Ledesma B, Laginhas C. Removal of amitriptyline from simulated gastric and intestinal fluids using activated carbons. J Pharm Sci. 2011;100(12):5096–5099.
   PubMed Web of Science ®Google Scholar
• Rauws AG. Treatment of experimental imipramine intoxication by interrupting enteral cycles with activated charcoal. Naunyn-Schmied Arch Pharm. 1974;282(Suppl):R78.
   Google Scholar
• Arimori K, Furukawa E, Nakano M. Adsorption of imipramine onto activated-charcoal and a cation-exchange resin in macrogol-electrolyte solution. Chem Pharm Bull. 1992;40(11):3105–3107.
   Web of Science ®Google Scholar
• Hultén B, Adams R, Askenasi R, et al. Activated charcoal in tricyclic antidepressant poisoning. Hum Toxicol. 1988;7(4):307–310.
   PubMedGoogle Scholar
• Neuvonen PJ, Kannisto H, Hirvisalo EL. Effect of activated charcoal on absorption of tolbutamide and valproate in man. Eur J Clin Pharmacol. 1983;24(2):243–246.
   PubMed Web of Science ®Google Scholar
• Al-Shareef A, Buss D, Shetty H, et al. The effect of repeated-dose activated charcoal on the pharmacokinetics of sodium valproate in healthy volunteers. Br J Clin Pharmacol. 1997;43(1):109–111.
   PubMed Web of Science ®Google Scholar
• Cooper GM, Le Couteur DG, Richardson D, et al. A randomized clinical trial of activated charcoal for the routine management of oral drug overdose. QJM. 2005;98(9):655–660.
   PubMed Web of Science ®Google Scholar
• Spiller HA, Winter ML, Klein-Schwartz W, et al. Efficacy of activated charcoal administered more than four hours after acetaminophen overdose. J Emerg Med. 2006;30(1):1–5.
   PubMed Web of Science ®Google Scholar
• Chiew AL, Isbister GK, Page CB, et al. Modified release paracetamol overdose: a prospective observational study (ATOM-3). Clin Toxicol. 2018;56(9):810–819.
   PubMed Web of Science ®Google Scholar
• Magdalan J, Zawadzki M, Słoka T, et al. Suicidal overdose with relapsing clomipramine concentrations due to a large gastric pharmacobezoar. Forensic Sci Int. 2013;229(1-3):e19–e22.
   PubMed Web of Science ®Google Scholar
• Schmit G, De Boosere E, Vanhaebost J, et al. Bupropion overdose resulted in a pharmacobezoar in a fatal bupropion (wellbutrin(R)) sustained-release overdose: postmortem distribution of bupropion and its major metabolites. J Forensic Sci. 2017;62(6):1674–1676.
   PubMed Web of Science ®Google Scholar
• Hoegberg LCG, Refsgaard F, Pedersen SH, et al. Potential pharmacobezoar formation of large size extended-release tablets and their dissolution - an in vitro study. Clin Toxicol. 2019;57(4):271–281.
   PubMed Web of Science ®Google Scholar
• Li YK, Lam KF, Wong CLW, et al. In vitro study of pharmacobezoar formation in simulated acetaminophen overdose. Clin Toxicol. 2020;58(9):900–906.
   PubMed Web of Science ®Google Scholar
• Levy G, Tsuchiya T. Effect of activated charcoal on aspirin absorption in man. Part I. Clin Pharmacol Ther. 1972;13(3):317–322.
   PubMed Web of Science ®Google Scholar
• Hillman RJ, Prescott LF. Treatment of salicylate poisoning with repeated oral charcoal. Br Med J (Clin Res Ed). 1985;291(6507):1472.
   PubMedGoogle Scholar
• Mofenson HC, Caraccio TR, Greensher J, et al. Gastrointestinal dialysis with activated charcoal and cathartic in the treatment of adolescent intoxications. Clin Pediatr. 1985;24(12):678–684.
   PubMed Web of Science ®Google Scholar
• Cordonnier JA, Van den Heede MA, Heyndrickx AM. In vitro adsorption of tilidine HCl by activated charcoal. J Toxicol Clin Toxicol. 1986;24(6):503–517.
   PubMed Web of Science ®Google Scholar
• Hussain K, Bukhari NI, Danish MZ, et al. Adsorption of paracetamol on activated charcoal in the presence of dextropropoxyphene hydrochloride, N-acetylcysteine and sorbitol. Lat Am J Pharm. 2010;29(6):883–888.
   Web of Science ®Google Scholar
• Ronowicz J, Kupcewicz B, Pałkowski Ł, et al. Development and optimization of the activated charcoal suspension composition based on a mixture design approach. Acta Pharm. 2015;65(1):83–90.
   PubMed Web of Science ®Google Scholar
• Curd-Sneed CD, Parks KS, Bordelon JG, et al. In vitro adsorption of sodium pentobarbital by SuperChar, USP and darco G-60 activated charcoals. J Toxicol Clin Toxicol. 1987;25(1-2):1–11.
   PubMed Web of Science ®Google Scholar
• Ryan CF, Spigiel RW, Zeldes G. Enhanced adsorptive capacity of activated charcoal in the presence of magnesium citrate, N.F. Clin Toxicol. 1980;17(3):457–461.
   PubMed Web of Science ®Google Scholar
• Orisakwe OE, Akintonwa A. Effect on sodium sulphate on the adsorption of chloroquine and mefloquine to activated charcoal. East Afr Med J. 1991;68(6):420–424.
   PubMed Web of Science ®Google Scholar
• Orisakwe OE, Afonne OJ, Agbasi PU, et al. Adsorptive capacity of activated charcoal for rifampicin with and without sodium chloride and sodium citrate. Biol Pharm Bull. 2001;24(6):724–726.
   PubMed Web of Science ®Google Scholar
• Afonne OJ, Orisakwe OE, Ofuefule SI, et al. Saline cathartics and adsorptive capacity of activated charcoal for doxycycline. Acta Pol Pharm. 2002;59(3):177–179.
   PubMedGoogle Scholar
• Akintonwa A, Orisakwe OE. The adsorption of metronidazole and tinidazole to activated charcoal and the effect of magnesium sulfate. Vet Hum Toxicol. 1988;30(6):556–558.
   PubMedGoogle Scholar
• Akintonwa A, Orisakwe OE. The adsorption of quinine and quinidine to activated charcoal with and without magnesium sulfate. Vet Hum Toxicol. 1990;32(6):567–568.
   PubMedGoogle Scholar
• Lapierre G, Algozzine G, Doering PL. Effect of magnesium citrate on the in vitro adsorption of aspirin by activated charcoal. Clin Toxicol. 1981;18(7):793–796.
   PubMed Web of Science ®Google Scholar
• Gaudreault P, Friedman PA, Lovejoy FH. Jr. Efficacy of activated charcoal and magnesium citrate in the treatment of oral paraquat intoxication. Ann Emerg Med. 1985;14(2):123–125.
   PubMed Web of Science ®Google Scholar
• Kirshenbaum LA, Sitar DS, Tenenbein M. Interaction between Whole-Bowel irrigation solution and activated charcoal implications for the treatment of toxic ingestions. Ann Emerg Med. 1990;19(10):1129–1132.
   PubMed Web of Science ®Google Scholar
• Makosiej FJ, Hoffman RS, Howland MA, et al. An in vitro evaluation of cocaine hydrochloride adsorption by activated charcoal and desorption upon addition of polyethylene glycol electrolyte lavage solution. J Toxicol Clin Toxicol. 1993;31(3):381–395.
   PubMed Web of Science ®Google Scholar
• Hoffman RS, Chiang WK, Howland MA, et al. Theophylline desorption from activated charcoal caused by whole bowel irrigation solution. J Toxicol Clin Toxicol. 1991;29(2):191–201.
   PubMed Web of Science ®Google Scholar
• Atta-Politou J, Macheras PE, Koupparis MA. The effect of polyethylene glycol on the charcoal adsorption of chlorpromazine studied by ion selective electrode potentiometry. J Toxicol Clin Toxicol. 1996;34(3):307–316.
   PubMed Web of Science ®Google Scholar
• Van de Graaff WB, Thompson WL, Sunshine I, et al. Adsorbent and cathartic inhibition of enteral drug absorption. J Pharmacol Exp Ther. 1982;221(3):656–663.
   PubMed Web of Science ®Google Scholar
• Koenigshof AM, Beal MW, Poppenga RH, et al. Effect of sorbitol, single, and multidose activated charcoal administration on carprofen absorption following experimental overdose in dogs. J Vet Emerg Crit Care. 2015;25(5):606–610.
   PubMed Web of Science ®Google Scholar
• Picchioni AL, Chin L, Gillespie T. Evaluation of activated charcoal-sorbitol suspension as an antidote. J Toxicol Clin Toxicol. 1982;19(5):433–444.
   PubMed Web of Science ®Google Scholar
• Galey FD, Lambert RJ, Busse M, et al. Therapeutic efficacy of superactive charcoal in rats exposed to oral lethal doses of T-2 toxin. Toxicon. 1987;25(5):493–499.
   PubMed Web of Science ®Google Scholar
• Keller RE, Schwab RA, Krenzelok EP. Contribution of sorbitol combined with activated charcoal in prevention of salicylate absorption. Ann Emerg Med. 1990;19(6):654–656.
   PubMed Web of Science ®Google Scholar
• Smilkstein MJ, Steedle D, Kulig KW, et al. Magnesium levels after magnesium-containing cathartics. J Toxicol Clin Toxicol. 1988;26(1–2):51–65.
   PubMed Web of Science ®Google Scholar
• Neuvonen PJ, Olkkola KT. Effect of purgatives on antidotal efficacy of oral activated charcoal. Hum Toxicol. 1986;5(4):255–263.
   PubMedGoogle Scholar
• Menzies DG, Busuttil A, Prescott LF. Fatal pulmonary aspiration of oral activated charcoal. BMJ. 1988;297(6646):459–460.
   PubMedGoogle Scholar
• Benson B, Vanantwerp M, Hergott T. A fatality resulting from multiple dose activated charcoal therapy. Vet Hum Toxicol. 1989;31(4):335.
   Google Scholar
• Elliott CG, Colby TV, Kelly TM, et al. Charcoal lung. Bronchiolitis obliterans after aspiration of activated charcoal. Chest. 1989;96(3):672–674.
   PubMed Web of Science ®Google Scholar
• Varga DW, Roy TM, Ossorio MA. Gastric stapling: a significant risk factor in the treatment of tricyclic antidepressant overdose. J Ky Med Assoc. 1989;87(10):501–503.
   PubMedGoogle Scholar
• Weber CA, Santiago RM. Hypermagnesemia. A potential complication during treatment of theophylline intoxication with oral activated charcoal and magnesium-containing cathartics. Chest. 1989;95(1):56–59.
   PubMed Web of Science ®Google Scholar
• Longdon P, Henderson A. Intestinal pseudo-obstruction following the use of enteral charcoal and sorbitol and mechanical ventilation with papaveretum sedation for theophylline poisoning. Drug Saf. 1992;7(1):74–77.
   PubMed Web of Science ®Google Scholar
• Wax PM. Intestinal infarction due to nifedipine overdose [conference paper]. J Toxicol Clin Toxicol. 1995;33(6):725–728.
   PubMed Web of Science ®Google Scholar
• Aaron CK, Primack WA, Manno MA. Cardiac arrest from aspirated magnesium citrate/charcoal slurry. J Toxicol Clin Toxicol. 1997;35(5):505.
   Google Scholar
• French LK, McKeown NJ, Hendrickson RG. Continuous renal replacement therapy for salicylate overdose in a patient with mutli-system trauma. Clin Toxicol. 2011;49(6):541–542.
   Web of Science ®Google Scholar
• Boyd R, Hanson J. Prospective single blinded randomised controlled trial of two orally administered activated charcoal preparations. J Accid Emerg Med. 1999;16(1):24–25.
   PubMedGoogle Scholar
• Stremski E, Galustyan S, Yen K, et al. Use of activated charcoal versus superactivated charcoal for pediatric gastric decontamination. Pediatr Res. 2002;51(4 Part 2):87A.
   PubMed Web of Science ®Google Scholar
• Vernet D, Garcia R, Plana S, et al. Gastrointestinal decontamination for acute medication poisoning: implementation of advanced triage for activated charcoal administration. Emergencias. 2014;26(6):431–436.
   Web of Science ®Google Scholar
• Cumpston K, Stromberg P, Wills BK, et al. Activated charcoal does not reduce duration of phenytoin toxicity in hospitalized patients. Am J Ther. 2016;23(3):e773–e777.
   PubMed Web of Science ®Google Scholar
• Orfanidou G, Chalkias A, Koutsovasilis A, et al. Activated charcoal may not be necessary in all oral overdoses of medication. Am J Emerg Med. 2016;34(2):319–321.
   PubMed Web of Science ®Google Scholar
• Cantrell FL, Sun C. Poison control system's 15-year experience of multiple dose-activated charcoal administration. Am J Ther. 2019;26(4):e541–e542.
   PubMed Web of Science ®Google Scholar
• Walker R, Black S. BS. Single dose activated charcoal for pre-hospital use, a feasibility study by South Western ambulance service nhs foundation trust. Emerg Med J. 2015;32(5):e3–e4.
   PubMedGoogle Scholar
• Moll J, Kerns W, Tomaszewski C, et al. Incidence of aspiration pneumonia in intubated patients receiving activated charcoal. J Emerg Med. 1999;17(2):279–283.
   PubMed Web of Science ®Google Scholar
• Watson WA, Weinman SA, Group TAS. Activated charcoal (AC) dosing and the prevalence and predictors of emesis. J Toxicol Clin Toxicol. 1995;33(5):489–490.
   Google Scholar
• Villarreal J, Kahn CA, Dunford JV, et al. A retrospective review of the prehospital use of activated charcoal. Am J Emerg Med. 2015;33(1):56–59.
   PubMed Web of Science ®Google Scholar
• Alaspaa AO, Kuisma MJ, Hoppu K, et al. Out-of-hospital administration of activated charcoal by emergency medical services. Ann Emerg Med. 2005;45(2):207–212.
   PubMed Web of Science ®Google Scholar
• Harchelroad F, Cottington E, Krenzelok EP. Gastrointestinal transit times of a charcoal/sorbitol slurry in overdose patients . J Toxicol Clin Toxicol. 1989;27(1-2):91–100.
   PubMed Web of Science ®Google Scholar
• Sessler CN. Poor tolerance of oral activated charcoal with theophylline overdose. Am J Emerg Med. 1987;5(6):492–495.
   PubMed Web of Science ®Google Scholar
• Amigó M, Nogué S, Sanjurjo E, et al. Efficacy and safety of gut decontamination in patients with acute therapeutic drug overdose. Med Clin. 2004;122(13):487–492.
   PubMed Web of Science ®Google Scholar
• Amigo M, Nogue S, Miro O. Use of activated charcoal in acute poisonings: clinical safety and factors associated with adverse reactions in 575 cases. Medicina Clinica. 2010;135(6):243–249.
   PubMed Web of Science ®Google Scholar
• Liisanantti J, Kaukoranta P, Martikainen M, et al. Aspiration pneumonia following severe self-poisoning. Resuscitation. 2003;56(1):49–53.
   PubMed Web of Science ®Google Scholar
• Minocha A, Herold DA, Bruns DE, et al. Effect of activated charcoal in 70% sorbitol in healthy individuals. J Toxicol Clin Toxicol. 1984;22(6):529–536.
   PubMed Web of Science ®Google Scholar
• Woodard JA, Shannon M, Lacouture PG, et al. Serum magnesium concentrations after repetitive magnesium cathartic administration. Am J Emerg Med. 1990;8(4):297–300.
   PubMed Web of Science ®Google Scholar
• Do SI, Park S, Ha H, et al. Fatal pulmonary complications associated with activated charcoal: an autopsy case. Basic Appl Pathol. 2009;2(3):106–108.
   Google Scholar
• Hack JB, Meggs WJ, Gilliland MGB. Activated charcoal aspiration: death in a dose. Clin Toxicol. 2005;43(6):679.
   Web of Science ®Google Scholar
• Sood BR, Bhan A, Chakrabarti A. A study on the haemodynamic interactions between activated charcoal and propranolol/atenolol in normal human subjects. Indian J Physiol Pharmacol. 1999;43(1):109–113.
   PubMedGoogle Scholar
• Isbister GK, Friberg LE, Stokes B, et al. Activated charcoal decreases the risk of QT prolongation after citalopram overdose. Ann Emerg Med. 2007;50(5):593–600.
   PubMed Web of Science ®Google Scholar
• Chaput de Saintonge DM, Herxheimer A. Activated charcoal impairs propantheline absorption. Eur J Clin Pharmacol. 1971;4(1):52–53.
   PubMed Web of Science ®Google Scholar
• Passeron D, Bermudez A, Riviere R. Assessment of the efficacy of giving activated-charcoal in 70-percent sorbitol solution during the acute poisonings. J Toxicol Clin Exp. 1989;9(4):277–281.
   PubMedGoogle Scholar
• Merigian KS, Blaho KE. Single-dose oral activated charcoal in the treatment of the self-poisoned patient: a prospective, randomized, controlled trial. Am J Ther. 2002;9(4):301–308.
   PubMedGoogle Scholar
• Karkkainen S, Neuvonen PJ. Effect of oral charcoal and urine pH on sotalol pharmacokinetics. Int J Clin Pharmacol Ther Toxicol. 1984;22(8):441–446.
   PubMedGoogle Scholar
• Laine K, Kivisto KT, Neuvonen PJ. Effect of delayed administration of activated charcoal on the absorption of conventional and slow-release verapamil. J Toxicol Clin Toxicol. 1997;35(3):263–268.
   PubMed Web of Science ®Google Scholar
• Tanaka C, Ohtani H, Tsujimoto M, et al. Effects of dosing interval on the pharmacokinetic interaction between oral small spherical activated charcoal and amlodipine in humans. J Clin Pharmacol. 2007;47(7):904–908.
   PubMed Web of Science ®Google Scholar
• Laine K, Kivisto KT, Laakso I, et al. Prevention of amlodipine absorption by activated charcoal: effect of delay in charcoal administration. Br J Clin Pharmacol. 1997;43(1):29–33.
   PubMed Web of Science ®Google Scholar
• Karkkainen S, Neuvonen PJ. Pharmacokinetics of amitriptyline influenced by oral charcoal and urine pH. Int J Clin Pharmacol Ther Toxicol. 1986;24(6):326–332.
   PubMedGoogle Scholar
• Karkkainen S, Wuorela H, Vapaatalo H, et al. Effects of oral charcoal sodium BiCarbonate and ammonium chloride on amitriptyline pharmaco kinetics. Acta Pharmacol Toxicol Suppl. 1983;53(1):135.
   PubMedGoogle Scholar
• Dawling S, Crome P, Braithwaite R. Effect of delayed administration of activated charcoal on nortriptyline absorption. Eur J Clin Pharmacol. 1978;14(6):445–447.
   PubMed Web of Science ®Google Scholar
• Laine K, Kivisto KT, Pelttari S, et al. The effect of activated charcoal on the absorption of fluoxetine, with special reference to delayed charcoal administration. Pharmacol Toxicol. 1996;79(5):270–273.
   PubMedGoogle Scholar
• Greb WH, Buscher G, Dierdorf HD, et al. Ability of charcoal to prevent absorption of paroxetine. Acta Psychiatr Scand Suppl. 1989;350:156–157.
   PubMedGoogle Scholar
• Scheinin M, Virtanen R, Iisalo E. Effect of single and repeated doses of activated charcoal on the pharmacokinetics of doxepin. Int J Clin Pharmacol Ther Toxicol. 1985;23(1):38–42.
   PubMedGoogle Scholar
• Sorby DL. Effect of adsorbents on drug absorption. I. Modification of promazine absorption by activated attapulgite and activated charcoal. J Pharm Sci. 1965;54(5):677–683.
   PubMed Web of Science ®Google Scholar
• Laufen H, Leitold M. The effect of activated charcoal on the bioavailability of piroxicam in man. Int J Clin Pharmacol Ther Toxicol. 1986;24(1):48–52.
   PubMedGoogle Scholar
• el-Bahie N, Allen EM, Williams J, et al. The effect of activated charcoal and hyoscine butylbromide alone and in combination on the absorption of mefenamic acid. Br J Clin Pharmacol. 1985;19(6):836–838.
   PubMed Web of Science ®Google Scholar
• Karkkainen S, Neuvonen PJ. Effect of oral charcoal and urine pH on dextropropoxyphene pharmacokinetics. Int J Clin Pharmacol Ther Toxicol. 1985;23(4):219–225.
   PubMedGoogle Scholar
• Chernish SM, Wolen RL, Rodda BE. Adsorption of propoxyphene hydrochloride by activated charcoal. Clin Toxicol. 1972;5(3):317–329.
   PubMed Web of Science ®Google Scholar
• Laine K, Kivisto KT, Ojala-Karlsson P, et al. Effect of activated charcoal on the pharmacokinetics of pholcodine, with special reference to delayed charcoal ingestion. Ther Drug Monit. 1997;19(1):46–50.
   PubMed Web of Science ®Google Scholar
• Kivisto KT, Neuvonen PJ. Effect of activated charcoal on the absorption of amiodarone. Hum Exp Toxicol. 1991;10(5):327–329.
   PubMed Web of Science ®Google Scholar
• Hartel G, Manninen V, Reissell P. Treatment of digoxin intoxication. Lancet. 1973;302(7821):158.
   Google Scholar
• Sorri A, Keranan T, Moilanen E, et al. The effect of oral activated charcoal on the absorption and elimination of lamotrigine. Epilepsia. 1998;39(suppl. 6):53.
   Google Scholar
• Keranen T, Sorri A, Moilanen E, et al. Effects of charcoal on the absorption and elimination of the antiepileptic drugs lamotrigine and oxcarbazepine. Arzneimittelforschung. 2010;60(7):421–426.
   PubMed Web of Science ®Google Scholar
• Madu EP. Can co-administration of sulfadoxine-pyremathamine and single-dose activated charcoal reduce the chances of adverse reactions in cases of inadvertent repeat dose? Int J Pharmacol. 2016;12(6):605–611.
   Google Scholar
• Akintonwa A, Obodozie O. Effect of activated charcoal on the disposition of sulphadoxine. Arch Int Pharmacodyn Ther. 1991;309:185–192.
   PubMedGoogle Scholar
• Orisakwe OE, Ilondu NA, Afonne OJ, et al. Acceleration of body clearance of diethylcarbamazine by oral activated charcoal. Pharmacol Res. 2000;42(2):167–170.
   PubMed Web of Science ®Google Scholar
• Orisakwe OE, Ilondu ND, Afonne OJ, et al. Effect of activated charcoal on diethylcarbamazine absorption in humans. Am J Ther. 2001;8(1):7–9.
   PubMedGoogle Scholar
• de Souza JB, Okomo U, Alexander ND, et al. Oral activated charcoal prevents experimental cerebral malaria in mice and in a randomized controlled clinical trial in man did not interfere with the pharmacokinetics of parenteral artesunate. PLoS One. 2010;5(4):e9867.
   PubMed Web of Science ®Google Scholar
• Akintonwa A, Orisakwe LOE. Effect of activated charcoal on chloroquine absorption in man. Niger J Physiol Sci. 1990;6(1):18–21.
   Google Scholar
• Neuvonen PJ, Kivisto KT, Laine K, et al. Prevention of chloroquine absorption by activated charcoal. Hum Exp Toxicol. 1992;11(2):117–120.
   PubMed Web of Science ®Google Scholar
• Scolding N, Ward MJ, Hutchings A, et al. Charcoal and isoniazid pharmacokinetics. Hum Toxicol. 1986;5(4):285–286.
   PubMedGoogle Scholar
• Siefkin AD, Albertson TE, Corbett MG. Isoniazid overdose: pharmacokinetics and effects of oral charcoal in treatment. Hum Toxicol. 1987;6(6):497–501.
   PubMedGoogle Scholar
• Tenenbein M, Cohen S, Sitar DS. Efficacy of ipecac-induced emesis, orogastric lavage, and activated charcoal for acute drug overdose. Ann Emerg Med. 1987;16(8):838–841.
   PubMed Web of Science ®Google Scholar
• Orisakwe OE, Dioka CE, Okpogba AN, et al. Effect of activated charcoal on rifampicin absorption in man. Tokai J Exp Clin Med. 1996;21(1):51–54.
   PubMedGoogle Scholar
• Torre D, Sampietro C, Quadrelli C, et al. Effects of orally administered activated charcoal on ciprofloxacin pharmacokinetics in healthy volunteers. Chemioterapia. 1988;7(6):382–386.
   PubMedGoogle Scholar
• Laine K, Kivisto KT, Neuvonen PJ. The effect of activated charcoal on the absorption and elimination of astemizole. Hum Exp Toxicol. 1994;13(7):502–505.
   PubMed Web of Science ®Google Scholar
• Guay DRP, Meatherall RC, Macaulay PA, et al. Activated charcoal adsorption of diphenhydramine. Int J Clin Pharmacol Ther Toxicol. 1984;22(8):395–400.
   PubMedGoogle Scholar
• Neuvonen PJ, Karkkainen S. Effects of charcoal, sodium bicarbonate, and ammonium chloride on chlorpropamide kinetics. Clin Pharmacol Ther. 1983;33(3):386–393.
   PubMed Web of Science ®Google Scholar
• Kivisto KT, Neuvonen PJ. The effect of cholestyramine and activated charcoal on glipizide absorption. Br J Clin Pharmacol. 1990;30(5):733–736.
   PubMed Web of Science ®Google Scholar
• Massanari MJ, Hendeles L, Hill E, et al. The efficacy of sorbitol and activated charcoal in reducing theophylline absorption from a Slow-Release formulation. Drug Intell Clin Pharm. 1986;20(6):471.
   Google Scholar
• Kivisto KT, Neuvonen PJ. Effect of activated charcoal on frusemide induced diuresis: a human class experiment for medical students. Br J Clin Pharmacol. 1990;30(3):496–498.
   PubMed Web of Science ®Google Scholar
• Tsuchiya T, Levy G. Drug adsorption efficacy of commercial activated charcoal tablets in vitro and in man. J Pharm Sci. 1972;61(4):624–625.
   PubMed Web of Science ®Google Scholar
• Klein-Schwartz W, Doyon S, Dowling T. Drug adsorption efficacy and palatability of a novel charcoal cookie formulation. Pharmacotherapy. 2010;30(9):888–894.
   PubMed Web of Science ®Google Scholar
• Heimer GM, Englund DE. Enterohepatic recirculation of oestriol: inhibition by activated charcoal. Acta Endocrinol. 1986;113(1):93–95.
   PubMedGoogle Scholar
• Tischio J, Harris W, Hetyei N. Effect of an oral administration of charcoal on the gastro intestinal absorption and bio availability of loperamide hydro chloride in man. Clin Res. 1980;28(2).
   Google Scholar
• Eyer P, Sprenger M. Oral administration of activated charcoal-sorbitol suspension as first aid in prevention of poison resorption? Klin Wochenschr. 1991;69(19):887–894.
   PubMedGoogle Scholar
• Lapatto-Reiniluoto O, Kivistö KT, Neuvonen PJ. Gastric decontamination performed 5 min after the ingestion of temazepam, verapamil and moclobemide: charcoal is superior to lavage. Br J Clin Pharmacol. 2000;49(3):274–278.
   PubMed Web of Science ®Google Scholar
• Lapatto-Reiniluoto O, Kivistö KT, Neuvonen PJ. Efficacy of activated charcoal versus gastric lavage half an hour after ingestion of moclobemide, temazepam, and verapamil. Eur J Clin Pharmacol. 2000;56(4):285–288.
   PubMed Web of Science ®Google Scholar
• Lapatto-Reiniluoto O, Kivistö KT, Neuvonen PJ. Effect of activated charcoal alone or given after gastric lavage in reducing the absorption of diazepam, ibuprofen and citalopram. Br J Clin Pharmacol. 1999;48(2):148–153.
   PubMed Web of Science ®Google Scholar
• Neuvonen PJ, Olkkola KT. Activated charcoal and syrup of ipecac in prevention of cimetidine and pindolol absorption in man after administration of metoclopramide as an antiemetic agent. J Toxicol Clin Toxicol. 1984;22(2):103–114.
   PubMed Web of Science ®Google Scholar
• Neuvonen PJ, Olkkola KT. Effect of dose of charcoal on the absorption of disopyramide, indomethacin and trimethoprim by man. Eur J Clin Pharmacol. 1984;26(6):761–767.
   PubMed Web of Science ®Google Scholar
• Merigian KS, Woodard M, Hedges JR, et al. Prospective evaluation of gastric emptying in the self-poisoned patient. Am J Emerg Med. 1990;8(6):479–483.
   PubMed Web of Science ®Google Scholar
• Al-Abri SA, Orengo JP, Hayashi S, et al. Delayed bupropion cardiotoxicity associated with elevated serum concentrations of bupropion but not hydroxybupropion. Clin Toxicol. 2013;51(10):1230–1234.
   PubMed Web of Science ®Google Scholar
• Furlanut M, Bettio D, Bertin I, et al. Orphenadrine serum levels in a poisoned patient. Hum Toxicol. 1985;4(3):331–333.
   PubMedGoogle Scholar
• Hoetelmans RM, Otten JM, Koks CH, et al. Combined dapsone and clofazimine intoxication [case reports]. Hum Exp Toxicol. 1996;15(8):625–628.
   PubMed Web of Science ®Google Scholar
• de Olano J, Howland MA, Su MK, et al. Toxicokinetics of hydroxychloroquine following a massive overdose. The American J Emerg Med. 2019;37(12):2264.
   PubMed Web of Science ®Google Scholar
• Farley TA. Severe hypernatremic dehydration after use of an activated charcoal-sorbitol suspension. J Pediatr. 1986;109(4):719–722.
   PubMed Web of Science ®Google Scholar
• Jain R, Tholl DA. Activated charcoal for theophylline toxicity in a premature infant on the second day of life. Dev Pharmacol Ther. 1992;19(2–3):106–110.
   PubMedGoogle Scholar
• Aks SE, Krantz A, Hryhrczuk DO, et al. Acute accidental lindane ingestion in toddlers. Ann Emerg Med. 1995;26(5):647–651.
   PubMed Web of Science ®Google Scholar
• Duffull SB, Isbister GK. Predicting the requirement for N-acetylcysteine in paracetamol poisoning from reported dose. Clin Toxicol. 2013;51(8):772–776.
   PubMed Web of Science ®Google Scholar
• Spiller HA, Krenzelok EP, Grande GA, et al. A prospective evaluation of the effect of activated charcoal before oral N-acetylcysteine in acetaminophen overdose. Ann Emerg Med. 1994;23(3):519–523.
   PubMed Web of Science ®Google Scholar
• Winnicka RI, Topaciński B, Szymczak WM, et al. Carbamazepine poisoning: elimination kinetics and quantitative relationship with carbamazepine 10,11-epoxide. J Toxicol Clin Toxicol. 2002;40(6):759–765.
   PubMed Web of Science ®Google Scholar
• Page CB, Duffull SB, Whyte IM, et al. Promethazine overdose: clinical effects, predicting delirium and the effect of charcoal. QJM. 2009;102(2):123–131.
   PubMed Web of Science ®Google Scholar
• Cooper JM, Duffull SB, Saiao AS, et al. The pharmacokinetics of sertraline in overdose and the effect of activated charcoal. Br J Clin Pharmacol. 2015;79(2):307–315.
   PubMed Web of Science ®Google Scholar
• Bourdon H, Arditti J, Jean P, et al. Toxicokinetic study of 10 patients with acute maprotiline poisoning given activated-charcoal. J Toxicol Clin Exp. 1989;9(4):291–293.
   PubMedGoogle Scholar
• Kumar VV, Oscarsson S, Friberg LE, et al. The effect of decontamination procedures on the pharmacokinetics of venlafaxine in overdose. Clin Pharmacol Ther. 2009;86(4):403–410.
   PubMed Web of Science ®Google Scholar
• McFee RB, Caraccio TR, Mofenson HC. Selected tricyclic antidepressant ingestions involving children 6 years old or less. Acad Emergency Med. 2001;8(2):139–144.
   PubMed Web of Science ®Google Scholar
• Hedges JR, Otten EJ, Schroeder TJ, et al. Correlation of initial amitriptyline concentration reduction with activated charcoal therapy in overdose patients. Am J Emerg Med. 1987;5(1):48–51.
   PubMed Web of Science ®Google Scholar
• Desrochers J, Wojciechowski J, Klein-Schwartz W, et al. Bayesian forecasting tool to predict the need for antidote in acute acetaminophen overdose. Pharmacotherapy. 2017;37(8):916–926.
   PubMed Web of Science ®Google Scholar
• Nitsch J, Kohler U, Neyses L, et al. Inhibition of flecainide absorption by activated charcoal. Am J Cardiol. 1987;60(8):753.
   PubMed Web of Science ®Google Scholar
• Beuhler MC, Watson WA. The outcome of accidental mushroom ingestions in children with various decontamination treatments: an analysis of 14 years of TESS data. Clin Toxicol. 2009;43(6):437–443.
   Google Scholar
• Moon J, Chun B, Song K. An exploratory study; the therapeutic effects of premixed activated charcoal-sorbitol administration in patients poisoned with organophosphate pesticide [observational study]. Clin Toxicol. 2015;53(2):119–126.
   Web of Science ®Google Scholar
• Behnoush B, Bazmi E, Taghaddosinejad F. Carbamazepine poisoning and effect of multiple-dose activated charcoal. Acta Med Iran. 2009;47(1):9–14.
   Google Scholar
• Skinner CG, Chang AS, Matthews AS, et al. Randomized controlled study on the use of multiple-dose activated charcoal in patients with supratherapeutic phenytoin levels. Clin Toxicol. 2012;50(8):764–769.
   Web of Science ®Google Scholar
• Bouget J, Breurec JY, Baert A, et al. Value of oral activated-charcoal in emergency patients with intended benzodiazepine poisoning. J Toxicol Clin Exp. 1989;9(4):287–289.
   PubMedGoogle Scholar
• Du Souich P, Caille G, Larochelle P. Enhancement of nadolol elimination by activated charcoal and antibiotics. Clin Pharmacol Ther. 1983;33(5):585–590.
   PubMed Web of Science ®Google Scholar
• Goldberg MJ, Park GD, Spector R, et al. Lack of effect of oral activated charcoal on imipramine clearance. Clin Pharmacol Ther. 1985;38(3):350–353.
   PubMed Web of Science ®Google Scholar
• Allen EM, Buss DC, Williams J, et al. The effect of charcoal on mefenamic acid elimination. Br J Clin Pharmacol. 1987;24(6):830–832.
   PubMed Web of Science ®Google Scholar
• Ferry DG, Gazeley LR, Busby WJ, et al. Enhanced elimination of piroxicam by administration of activated charcoal or cholestyramine. Eur J Clin Pharmacol. 1990;39(6):599–601.
   PubMed Web of Science ®Google Scholar
• Belz GG. Plasma concentrations of intravenous beta-methyl digoxin with and without oral charcoal. Klin Wochenschr. 1974;52(15):749–750.
   PubMedGoogle Scholar
• Belz GG, Bader H. Effect of oral charcoal on plasma levels of intravenous methyl proscillaridin. Klin Wochenschr. 1974;52(23):1134–1135.
   PubMedGoogle Scholar
• Arimori K, Kawano H, Nakano M. Gastrointestinal dialysis of disopyramide in healthy subjects. Int J Clin Pharmacol Ther Toxicol. 1989;27(6):280–284.
   PubMedGoogle Scholar
• Goldberg MJ, Berlinger WG, Berg MJ. The effect of oral activated charcoal on the elimination of phenobarbital. Clin Res. 1982;30(2):487A.
   Google Scholar
• Mauro LS, Mauro VF, Brown DL, et al. Enhancement of phenytoin elimination by multiple-dose activated charcoal. Ann Emerg Med. 1987;16(10):1132–1135.
   PubMed Web of Science ®Google Scholar
• Rowden AM, Spoor JE, Bertino JS. Jr. The effect of activated charcoal on phenytoin pharmacokinetics. Ann Emerg Med. 1990;19(10):1144–1147.
   PubMed Web of Science ®Google Scholar
• Lockey D, Bateman DN. Effect of oral activated charcoal on quinine elimination. Br J Clin Pharmacol. 1989;27(1):92–94.
   PubMed Web of Science ®Google Scholar
• Davis RL, Koup JR, Roon RA, et al. Effect of oral activated charcoal on tobramycin clearance. Antimicrob Agents Chemother. 1988;32(2):274–275.
   PubMed Web of Science ®Google Scholar
• Watson WA, Jenkins TC, Velasquez N, et al. Repeated oral doses of activated charcoal and the clearance of tobramycin, a non-absorbable drug. J Toxicol Clin Toxicol. 1987;25(3):171–184.
   PubMed Web of Science ®Google Scholar
• Stass H, Kubitza D, Moller JG, et al. Influence of activated charcoal on the pharmacokinetics of moxifloxacin following intravenous and oral administration of a 400 mg single dose to healthy males. Br J Clin Pharmacol. 2005;59(5):536–541.
   PubMed Web of Science ®Google Scholar
• Davis RL, Roon RA, Koup JR, et al. Effect of orally administered activated charcoal on vancomycin clearance. Antimicrob Agents Chemother. 1987;31(5):720–722.
   PubMed Web of Science ®Google Scholar
• Venho VM, Salonen RO, Mattila MJ. Modification of the pharmacokinetics of doxycycline in man by ferrous sulphate or charcoal. Eur J Clin Pharmacol. 1978;14(4):277–280.
   PubMed Web of Science ®Google Scholar
• Radomski L, Park GD, Goldberg MJ, et al. Model for theophylline overdose treatment with oral activated charcoal. Clin Pharmacol Ther. 1984;35(3):402–408.
   PubMed Web of Science ®Google Scholar
• O'Connor N, Greene S, Dargan P, et al. Prolonged clinical effects in modified-release amitriptyline poisoning. Clin Toxicol. 2006;44(1):77–80.
   Web of Science ®Google Scholar
• Vicas IMO. Digoxin overdose managed with multidose activated-charcoal. Vet Hum Toxicol. 1987;29(6):463.
   Google Scholar
• Ahmad RA, Ahmad AJ, Al-Jawadi AJ. A case of digoxin poisoning. J Fac Med Baghdad. 1985;27(4):75–78.
   Google Scholar
• Lake KD, Brown DC, Peterson CD. Digoxin toxicity: enhanced systemic elimination during oral activated charcoal therapy. Pharmacotherapy. 1984;4(3):161–163.
   PubMed Web of Science ®Google Scholar
• Pond S, Jacobs M, Marks J, et al. Treatment of digitoxin overdose with oral activated charcoal. Lancet. 1981;2(8256):1177–1178.
   PubMed Web of Science ®Google Scholar
• Hansen D, Jacobs M, Pond S, et al. Successful treatment of digitoxin overdose by repeated oral-administration of activated-charcoal. Vet Hum Toxicol. 1981;23(5):353.
   Google Scholar
• Sadeg N, Richecoeur J, Dumontet M. Propafenone poisoning. Therapie. 2003;58(4):381–383.
   PubMed Web of Science ®Google Scholar
• Payette A, Ghannoum M, Madore F, et al. Carbamazepine poisoning treated by multiple extracorporeal treatments. Clin Nephrol. 2015;83(3):184–188.
   PubMed Web of Science ®Google Scholar
• Jukic I, Tonkic A, Titlic M, et al. Multidose activated charcoal in the treatment of carbamazepine overdose with seizures: a case report. Arh Hig Rada Toksikol. 2005;56(4):333–338.
   PubMedGoogle Scholar
• Cheema N, Lu JJ. Multiple dose activated charcoal fails to reduce elimination half-life in a severe phenobarbital toxicity. Clin Toxicol. 2013;51(7):593.
   Web of Science ®Google Scholar
• Inotsume N, Kimoto A, Katsuya H, et al. Accelerated elimination of phenobarbital by oral activated charcoal suspensions with alkaline diuresis in an overdose patient. Jpn J Clin Pharmacol Ther. 1988;19(4):779–781.
   Google Scholar
• Veerman M, Espejo MG, Christopher MA, et al. Use of activated charcoal to reduce elevated serum phenobarbital concentration in a neonate. J Toxicol Clin Toxicol. 1991;29(1):53–58.
   PubMed Web of Science ®Google Scholar
• Howard CE, Roberts RS, Ely DS, et al. Use of multiple-dose activated charcoal in phenytoin toxicity. Ann Pharmacother. 1994;28(2):201–203.
   PubMed Web of Science ®Google Scholar
• Rakhmanina NY, Webster PA, Farrar HC, et al. Multiple-dose activated charcoal use in phenytoin intoxication enhances drug elimination. Clin Res. 1993;41(4).
   Google Scholar
• Weidle PJ, Skiest DJ, Forrest A. Multiple-dose activate charcoal as adjunct therapy after chronic phenytoin intoxication. Clin Pharm. 1991;10(9):711–714.
   PubMedGoogle Scholar
• Vannaprasaht S, Tiamkao S, Sirivongs D, et al. Acute valproic acid overdose: enhance elimination with multiple-doses activated charcoal. J Med Assoc Thai. 2009;92(8):1113–1115.
   PubMedGoogle Scholar
• Brubacher JR, Dahghani P, McKnight D. Delayed toxicity following ingestion of enteric-coated divalproex sodium (epival). J Emerg Med. 1999;17(3):463–467.
   PubMed Web of Science ®Google Scholar
• Elonen E, Neuvonen PJ, Halmekoski J, et al. Acute dapsone intoxication: a case with prolonged symptoms. Clin Toxicol. 1979;14(1):79–85.
   PubMed Web of Science ®Google Scholar
• Burkhart KK, Metcalf S, Shurnas E, et al. Exchange transfusion and multidose activated charcoal following vancomycin overdose. J Toxicol Clin Toxicol. 1992;30(2):285–294.
   PubMed Web of Science ®Google Scholar
• Kucukguclu S, Tuncok Y, Ozkan H, et al. Multiple-dose activated charcoal in an accidental vancomycin overdose. J Toxicol Clin Toxicol. 1996;34(1):83–86.
   PubMed Web of Science ®Google Scholar
• Neuvonen PJ, Elonen E, Haapanen EJ. Acute dapsone intoxication: clinical findings and effect of oral charcoal and haemodialysis on dapsone elimination. Acta Med Scand. 1983;214(3):215–220.
   PubMedGoogle Scholar
• Hoppu K, Tikanoja T, Tapanainen P, et al. Accidental astemizole overdose in young children. Lancet. 1991;338(8766):538–540.
   PubMed Web of Science ®Google Scholar
• Akhtar J, Cienki JJ, Donovan JW, et al. Treatment of ethchlorvynol poisoning with multiple doses of activated charcoal. J Toxicol Clin Toxicol. 1996;34(5):563.
   Google Scholar
• Honcharik N, Anthone S. Activated charcoal in acute cyclosporin overdose. Lancet. 1985;1(8436):1051.
   PubMed Web of Science ®Google Scholar
• Bronstein AC, Sawyer DR, Rumack BH, et al. Theophylline intoxication in a premature-infant - multiple dose activated-charcoal therapy. Vet Hum Toxicol. 1984;26(5):404.
   Google Scholar
• Rygnestad T, Walstad RA, Dahl K. Self-poisoning with theophylline. The effect of repeated doses oral charcoal on drug elimination. Acta Med Scand. 1986;219(4):425–427.
   PubMedGoogle Scholar
• Lopez-Herce J, Garcia Teresa MA, Ruiz Beltran A, et al. Severe theophylline toxicity treated with oral activated charcoal. Intensive Care Med. 1991;17(4):244–245.
   PubMed Web of Science ®Google Scholar
• Lopez-Herce J, Garcia Teresa MA. Theophylline poisoning: treatment with peritoneal dialysis or activated charcoal. An Esp Pediatr. 1994;40(6):462–463.
   Google Scholar
• Strauss AA, Modanlou HD, Komatsu G. Theophylline toxicity in a preterm infant: selected clinical aspects. Pediatr Pharmacol. 1985;5(3):209–212.
   PubMedGoogle Scholar
• Gal P, Miller A, McCue JD. Oral activated charcoal to enhance theophylline elimination in an acute overdose. JAMA. 1984;251(23):3130–3131.
   PubMed Web of Science ®Google Scholar
• Traeger SM, Haug MT. Reduction of diazepam serum half life and reversal of coma by activated charcoal in a patient with severe liver disease. J Toxicol Clin Toxicol. 1986;24(4):329–337.
   PubMed Web of Science ®Google Scholar
• Graudins A, Aaron CK. Delayed peak serum valproic acid in massive divalproex overdose-treatment with charcoal hemoperfusion . J Toxicol Clin Toxicol. 1996;34(3):335–341.
   PubMed Web of Science ®Google Scholar
• Tritsch L, Sauder P, Kopferschmitt J. Toxicokinetic studies during acute poisonings treated with activated-charcoal. J Toxicol Clin Exp. 1989;9(4):283–285.
   PubMedGoogle Scholar
• Swartz CM, Sherman A. The treatment of tricyclic antidepressant overdose with repeated charcoal. J Clin Psychopharmacol. 1984;4(6):336–340.
   PubMed Web of Science ®Google Scholar
• Ilett KF, Hackett LP, Dusci LJ, et al. Disposition of dothiepin after overdose: effects of repeated-dose activated charcoal. Ther Drug Monit. 1991;13(6):485–489.
   PubMed Web of Science ®Google Scholar
• Montoya-Cabrera M, Escalante-Galindo P, Nava-Juárez A, et al. Evaluation of the efficacy of N-acetylcysteine administered alone or in combination with activated charcoal in the treatment of acetaminophen overdoses. Gac Med Mex. 1999;135(3):239–243.
   PubMedGoogle Scholar
• Montoya-Cabrera MA, Sauceda-Garcia JM, Escalante-Galindo P, et al. Carbamazepine poisoning in adolescent suicide attempters. Effectiveness of multiple-dose activated charcoal in enhancing carbamazepine elimination. Arch Med Res. 1996;27(4):485–489.
   PubMed Web of Science ®Google Scholar
• Wason S, Baker RC, Carolan P, et al. Carbamazepine overdose--the effects of multiple dose activated charcoal. J Toxicol Clin Toxicol. 1992;30(1):39–48.
   PubMed Web of Science ®Google Scholar
• Boldy DA, Heath A, Ruddock S, et al. Activated charcoal for carbamazepine poisoning. Lancet. 1987;1(8540):1027.
   PubMed Web of Science ®Google Scholar
• Boldy DA, Vale JA, Prescott LF. Treatment of phenobarbitone poisoning with repeated oral administration of activated charcoal. Q J Med. 1986;61(235):997–1002.
   PubMedGoogle Scholar
• Vale JA, Ruddock FS, Boldy DAR. Multiple doses of activated-charcoal in the treatment of phenobarbitone and carbamazepine poisoning. Vet Hum Toxicol. 1987;29(2):152.
   Google Scholar
• Barker K, Ford M, Wright K, et al. Multiple dose activated charcoal as treatment of vancomycin toxicity in premature neonates. J Toxicol Clin Toxicol. 2002;40(5):685.
   Google Scholar
• Prescott LF, Hamilton AR, Heyworth R. Treatment of quinine overdosage with repeated oral charcoal. Br J Clin Pharmacol. 1989;27(1):95–97.
   PubMed Web of Science ®Google Scholar
• Hassan E. Treatment of meprobamate overdose with repeated oral doses of activated charcoal. Ann Emerg Med. 1986;15(1):73–76.
   PubMed Web of Science ®Google Scholar
• Amitai Y, Yeung AC, Moye J, et al. Repetitive oral activated charcoal and control of emesis in severe theophylline toxicity. Ann Intern Med. 1986;105(3):386–387.
   PubMed Web of Science ®Google Scholar
• Ohning BL, Reed MD, Blumer JL. Continuous nasogastric administration of activated charcoal for the treatment of theophylline intoxication. Pediatr Pharmacol. 1986;5(4):241–245.
   PubMedGoogle Scholar
• Sessler CN, Glauser FL, Cooper KR. Treatment of theophylline toxicity with oral activated charcoal. Chest. 1985;87(3):325–329.
   PubMed Web of Science ®Google Scholar
• True RJ, Berman JM, Mahutte CK. Treatment of theophylline toxicity with oral activated charcoal. Crit Care Med. 1984;12(2):113–114.
   PubMed Web of Science ®Google Scholar
• Berman JM, True RJ, Mahutte CK. Treatment of theophylline toxicity with oral activated-charcoal. Chest. 1983;84(3):331.
   Web of Science ®Google Scholar
• Bonal J, Mangues MA, Farre R. Increase of theophylline clearance by oral activated charcoal. Its application in intoxication treatment. J Pharm Clin. 1987;6(1):117–126.
   Google Scholar
• Gadgil SD, Damle SR, Advani SH, et al. Effect of activated charcoal on the pharmacokinetics of high-dose methotrexate. Cancer Treat Rep. 1982;66(5):1169–1171.
   PubMedGoogle Scholar
• Malgorn G, Leboucher B, Harry P, et al. Benzodiazepine poisoning in a neonate: clinical and toxicokinetic evaluation following enterodialysis with activated charcoal. Arch Pediatr. 2004;11(7):819–821.
   PubMed Web of Science ®Google Scholar
• Roberts D, Honcharik N, Sitar DS, et al. Diltiazem overdose: pharmacokinetics of diltiazem and its metabolites and effect of multiple dose charcoal therapy. J Toxicol Clin Toxicol. 1991;29(1):45–52.
   PubMed Web of Science ®Google Scholar
• Ibanez C, Carcas AJ, Frias J, et al. Activated charcoal increases digoxin elimination in patients. Int J Cardiol. 1995;48(1):27–30.
   PubMed Web of Science ®Google Scholar
• Escalante GP, Gonzalez FL, Ceron AA. Toxicology monitoring in carbamazepine poisoning. The effects of multiple dose activated charcoal. Toxicol Lett. 2016;259:S143.
   PubMed Web of Science ®Google Scholar
• Stremski ES, Brady WB, Prasad K, et al. Pediatric carbamazepine intoxication. Ann Emerg Med. 1995;25(5):624–630.
   PubMed Web of Science ®Google Scholar
• Mohammed Ebid AH, Abdel-Rahman HM. Pharmacokinetics of phenobarbital during certain enhanced elimination modalities to evaluate their clinical efficacy in management of drug overdose. Ther Drug Monit. 2001;23(3):209–216.
   PubMed Web of Science ®Google Scholar
• Chan BS, Sellors K, Chiew AL, et al. Use of multi-dose activated charcoal in phenytoin toxicity secondary to genetic polymorphism. Clin Toxicol. 2015;53(2):131–133.
   PubMed Web of Science ®Google Scholar
• Shannon MW, Woolf A. The efficacy of elimination enhancement procedures after theophylline intoxication. Vet Hum Toxicol. 1992;34(4):331.
   Google Scholar
• Mangues MA, Perez C, Castellano A, et al. [Increase in the clearance of theophylline with activated carbon]. Med Clin. 1986;87(7):306.
   PubMed Web of Science ®Google Scholar
• Zhou MJ, Cheng MP, Gao BC. Effect of gastric injection of medicinal charcoal and retention enema on organophosphorus poisoning. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi. 2007;25(9):562–563.
   PubMedGoogle Scholar
• Atta-Politou J, Skopelitis I, Apatsidis I, et al. In vitro study on fluoxetine adsorption onto charcoal using potentiometry. Eur J Pharm Sci. 2001;12(3):311–319.
   PubMed Web of Science ®Google Scholar
• Cooney DO, Thomason R. Adsorption of fluoxetine HCl by activated charcoal. J Pharm Sci. 1997;86(5):642–644.
   PubMed Web of Science ®Google Scholar
• Nabais JMV, Mouquinho A, Galacho C, et al. In vitro adsorption study of fluoxetine in activated carbons and activated carbon fibres. Fuel Process Technol. 2008;89(5):549–555.
   Web of Science ®Google Scholar
• Tsitoura A, Atta-Politou J, Koupparis MA. In vitro adsorption study of fluoxetine onto activated charcoal at gastric and intestinal pH using high performance liquid chromatography with fluorescence detector. J Toxicol Clin Toxicol. 1997;35(3):269–276.
   PubMed Web of Science ®Google Scholar
• Favin FD, Klein-Schwartz W, Oderda GM, et al. In vitro study of lithium carbonate adsorption by activated charcoal. J Toxicol Clin Toxicol. 1988;26(7):443–450.
   PubMed Web of Science ®Google Scholar
• Watling SM, Gehrke JC, Gehrke CW, et al. In vitro binding of lithium using the cation exchange resin sodium polystyrene sulfonate. Am J Emerg Med. 1995;13(3):294–296.
   PubMed Web of Science ®Google Scholar
• Cooney DO. A "superactive" charcoal for antidotal use in poisonings. Clin Toxicol. 1977;11(4):387–390.
   PubMed Web of Science ®Google Scholar
• Otto U, Stenberg B. The significance of the form of preparation for the degree of adsorption of medical charcoal. Lakartidningen. 1973;70(31):2729–2730.
   PubMedGoogle Scholar
• Raffa RB, Wu C, Stone DJ, et al. Determination of the adsorption of tramadol hydrochloride by activated charcoal in vitro and in vivo. J Pharmacol Toxicol Methods. 2000;43(3):205–210.
   PubMed Web of Science ®Google Scholar
• Sanvordeker DR, Dahani EZ. In vitro adsorption of diphenoxylate hydrochloride on activated charcoal and its relationship to pharmacological effects of drug in vivo. I. J Pharm Sci. 1975;64(11):1877–1879.
   PubMed Web of Science ®Google Scholar
• Arimori K, Deshimaru M, Furukawa E, et al. Adsorption of mexiletine onto activated charcoal in macrogol-electrolyte solution. Chem Pharm Bull. 1993;41(4):766–768.
   PubMed Web of Science ®Google Scholar
• Orisakwe OE, Ofoefule SI, Dioka CE, et al. Carbon black (N220): a possible role in poison management. Tokai J Exp Clin Med. 1995;20(2):67–70.
   PubMedGoogle Scholar
• Alegakis AK, Tzatzarakis MN, Tsatsakis AM, et al. In vitro study of oxytetracycline adsorption on activated charcoal. J Environ Sci Health B. 2000;35(5):559–569.
   PubMed Web of Science ®Google Scholar
• Ghazy FS, Kassem AA, Shalaby SH. Adsorption characteristics of certain antibiotics to veegum and activated charcoal. Pharmazie. 1984;39(12):821–823.
   PubMed Web of Science ®Google Scholar
• Ibezim EC, Ofoefule SI, Ejeahalaka CN, et al. In vitro adsorption of ciprofloxacin on activated charcoal and talc. Am J Ther. 1999;6(4):199–201.
   PubMedGoogle Scholar
• Honda Y, Nakano M, Nakano NI. Adsorption and prevention of gastrointestinal absorption of nalidixic acid by activated carbon beads. Chem Pharm Bull. 1986;34(10):4385–4388.
   PubMed Web of Science ®Google Scholar
• Janos I. [Adsorption of sulfanilamides on activated charcoal. Acta Pharm Hung. 1972;42(3):97–102.
   PubMedGoogle Scholar
• Neuvonen P, Kannisto H, Lankinen S. Capacity of two forms of activated charcoal to adsorb nefopam in vitro and to reduce its toxicity in vivo. J Toxicol Clin Toxicol. 1983;21(3):333–342.
   PubMed Web of Science ®Google Scholar
• Okonkwo CT, Nzekwe IT, Okorie O, et al. Comparative adsorption of spiramycin on veegum(R), activated charcoal and garcinia kola heckel (guttiferea) seed. Trop J Pharm Res. 2015;14(3):379–384.
   Web of Science ®Google Scholar
• Orisakwe OE, Akintonwa A. In-vitro adsorption studies of isoniazid. Hum Exp Toxicol. 1991;10(2):133–135.
   PubMed Web of Science ®Google Scholar
• Ganjian F, Cutie AJ, Jochsberger T. In vitro adsorption studies of cimetidine. J Pharm Sci. 1980;69(3):352–353.
   PubMed Web of Science ®Google Scholar
• Abe I, Kamaya H, Ueda I. Activated carbon as a biological model: comparison between activated carbon adsorption and oil-water partition coefficient for drug activity correlation. J Pharm Sci. 1988;77(2):166–168.
   PubMed Web of Science ®Google Scholar
• Herman RJ, Chaudhary A. In vitro binding of lorazepam and lorazepam glucuronide to cholestyramine, colestipol, and activated charcoal. Pharm Res. 1991;8(4):538–540.
   PubMed Web of Science ®Google Scholar
• Wurster DE, Alkhamis KA, Matheson LE. Prediction of the adsorption of diazepam by activated carbon in aqueous media. J Pharm Sci. 2003;92(10):2008–2016.
   PubMed Web of Science ®Google Scholar
• Chinouth RW, Czajka PA, Peterson RG. N-acetylcysteine adsorption by activated charcoal. Vet Hum Toxicol. 1980;22(6):392–394.
   PubMedGoogle Scholar
• Cooney DO. In vitro evidence for ipecac inactivation by activated charcoal. J Pharm Sci. 1978;67(3):426–427.
   PubMed Web of Science ®Google Scholar
• Cope RB. A screening study of xylitol binding in vitro to activated charcoal. Vet Hum Toxicol. 2004;46(6):336–337.
   PubMedGoogle Scholar
• Cooney DO. The treatment of ethylene glycol poisoning with activated charcoal. IRCS Med Sci Biochem. 1977;5(6):265.
   Google Scholar
• Tomaszewski C, Voorhees S, Wathen J, et al. Cocaine adsorption to activated charcoal in vitro. J Emerg Med. 1992;10(1):59–62.
   PubMed Web of Science ®Google Scholar
• Tomimaru A, Arimori K, Inotsume N, et al. Effect of activated charcoal and atropine on absorption and/or exsorption of organophosphorus compounds in rats. J Pharm Pharmacol. 1996;48(4):351–356.
   PubMed Web of Science ®Google Scholar
• Nakamura T, Kawasaki N, Tamura T, et al. In vitro adsorption characteristics of paraquat and diquat with activated carbon varying in particle size. Bull Environ Contam Toxicol. 2000;64(3):377–382.
   PubMed Web of Science ®Google Scholar
• Orisakwe OE, Obi N. In vitro and in vivo adsorption studies of diazinon. Hum Exp Toxicol. 1993;12(4):301–303.
   PubMed Web of Science ®Google Scholar
• Petris OR, Gazzi E, Sorodoc L, et al. Assessing the capacity of various substances to act as neutralizing treatment in organophosphoric acute intoxications. Rev Chim. 2015;66(2):230–232.
   Web of Science ®Google Scholar
• Zahoor M, Mahramanlioglu M. Adsorption of imidacloprid on powdered activated carbon and magnetic activated carbon. Chem Biochem Eng. 2011;25(1):55–63.
   Web of Science ®Google Scholar
• Okonek S, Setyadharma H, Borchert A, et al. Activated charcoal is as effective as fuller's earth or bentonite in paraquat poisoning. Klin Wochenschr. 1982;60(4):207–210.
   PubMedGoogle Scholar
• McGrath JC, Klein-Schwartz W, Coop A. The effectiveness of activated charcoal in adsorbing GBL. J Toxicol Clin Toxicol. 2002;40(5):686.
   Google Scholar
• Neijzen R, van Ardenne P, Sikma M, et al. Activated charcoal for GHB intoxication: an in vitro study. Eur J Pharm Sci. 2012;47(5):801–803.
   PubMed Web of Science ®Google Scholar
• Oderda GM, Klein-Schwartz W, Insley BM. In vitro study of boric acid and activated charcoal. J Toxicol Clin Toxicol. 1987;25(1–2):13–19.
   PubMed Web of Science ®Google Scholar
• Mohaideen MSP, Srinivasan GN, Kader J. Adsorption study of mercury on charcoal. Bull Electrochem. 2000;16(3):140–143.
   Google Scholar
• Olkkola KT. Does ethanol modify antidotal efficacy of oral activated charcoal studies in vitro and in experimental animals . J Toxicol Clin Toxicol. 1984;22(5):425–432.
   PubMed Web of Science ®Google Scholar
• Huang JD, Tzou MC. The effect of activated charcoal on the volume of distribution of drugs. J Pharm Sci. 1986;75(9):923–924.
   PubMed Web of Science ®Google Scholar
• Skopp G, Mikus G. An in vitro experiment on the interaction of charcoal or wheat bran with 11-nor-9-carboxy-DELTA(9)-tetrahydrocannabinol and its glucuronide. Anal Bioanal Chem. 2013;405(29):9449–9453.
   PubMed Web of Science ®Google Scholar
• Traub SJ, Nelson LS, Hoffman RS. In-vitro adsorption of copper and lead to activated charcoal. J Toxicol Clin Toxicol. 2001;39(5):520–521.
   Google Scholar
• Uges DRA, Buirs B, Sangster B. Treatment of 4-aminopyridine-poisoning after oral overdose: a proposal. Pharm Acta Helv. 1984;59(5-6):172–176.
   PubMedGoogle Scholar
• Van Ryn J, Sieger P, Kink-Eiband M, et al. Adsorption of dabigatran etexilate in water or dabigatran in pooled human plasma by activated charcoal in vitro. Blood Conference: 51st Annual Meeting of the American Society of Hematology, ASH New Orleans, LA United States Conference Start. 2009;114(22).
   Google Scholar
• Hoffman RS, Stringer JA, Feinberg RS, et al. Comparative efficacy of thallium adsorption by activated charcoal, prussian blue, and sodium polystyrene sulfonate. J Toxicol Clin Toxicol. 1999;37(7):833–837.
   PubMed Web of Science ®Google Scholar
• Verzijl JM, Joore JC, van Dijk A, et al. In vitro binding characteristics for cesium of two qualities of prussian blue, activated charcoal and Resonium-A. J Toxicol Clin Toxicol. 1992;30(2):215–222.
   PubMed Web of Science ®Google Scholar
• Parker WA. Metoclopramide adsorbent drug interaction. Can J Hosp Pharm. 1982;35(2):38.
   Google Scholar
• Rybolt TR, Burrell DE, Shults JM, et al. In vitro coadsorption of acetaminophen and N-acetylcysteine onto activated carbon powder. J Pharm Sci. 1986;75(9):904–906.
   PubMed Web of Science ®Google Scholar
• Burkhart KK, Martinez MA. The adsorption of isopropanol and acetone by activated charcoal. J Toxicol Clin Toxicol. 1992;30(3):371–375.
   PubMed Web of Science ®Google Scholar
• Harrestrup Andersen A. Experimental studies on the pharmacology of activated charcoal. II. The effect of pH on the adsorption by charcoal from aqueous solutions. Acta Pharmacol Toxicol. 1947;3(3):119–218.
   PubMedGoogle Scholar
• Kannisto H, Neuvonen PJ. Adsorption of sulfonylureas onto activated charcoal in vitro. J Pharm Sci. 1984;73(2):253–256.
   PubMed Web of Science ®Google Scholar
• Martin GJ, Alpert S. Comparative capacities of adsorptive agents for endogenously produced toxic chemicals. Am J Dig Dis. 1950;17(5):151–154.
   PubMedGoogle Scholar
• Rambourg-Schepens MO, Lecolier MD, Rambourg P, et al. A pharmaceutical formulation of activated charcoal. In vitro testing – first clinical use. J Toxicol Clin Exp. 1989;9(4):261–263.
   PubMedGoogle Scholar
• Sobczak H, Pawlaczyk J. Sorption of non-narcotic analgetic drugs of medicinal charcoal. Acta Pol Pharm. 1998;55(4):279–283.
   PubMedGoogle Scholar
• Sorby DL, Plein EM, Benmaman JD. Adsorption of phenothiazine derivatives by solid adsorbents. J Pharm Sci. 1966;55(8):785–794.
   PubMed Web of Science ®Google Scholar
• Alotaibi MA, Fataftah AK, Alkhanbashi K, et al. Dose determination of activated charcoal in management of amitriptyline-induced poisoning by reversed-phase high-performance liquid chromatography. Trop J Pharm Res. 2015;14(4):655–662.
   Web of Science ®Google Scholar
• Yousefi G, Bizhani M, Jamshidzadeh A, et al. Comparison of activated charcoal and sodium polystyrene sulfonate resin efficiency on reduction of amitriptyline oral absorption in rat as treatments for overdose and toxicities. Iran J Basic Med Sci. 2017;20(1):46–52.
   PubMed Web of Science ®Google Scholar
• Linakis JG, Lacouture PG, Eisenberg MS, et al. Administration of activated charcoal or sodium polystyrene sulfonate (kayexalate) as gastric decontamination for lithium intoxication: an animal model. Pharmacol Toxicol. 1989;65(5):387–389.
   PubMedGoogle Scholar
• Nabais JMV, Tinoco MT, Cruz-Morais J. In vivo adsorption study of fluoxetine using carbon materials. Carbon. 2010;48(2):565–567.
   Web of Science ®Google Scholar
• Halsas M, Sakkinen M, Honkavaara J, et al. Treatment of carprofen overdose in dogs-the effect of charcoal and sodium bicarbonate on bioavailability. Eur J Pharm Sci. 2006;28:S33.
   Web of Science ®Google Scholar
• Raekallio MR, Honkavaara JM, Säkkinen MS, et al. Effects of urine alkalization and activated charcoal on the pharmacokinetics of orally administered carprofen in dogs. Am J Vet Res. 2007;68(4):423–427.
   PubMed Web of Science ®Google Scholar
• Burton BT, Bayer MJ, Barron L, et al. Comparison of activated charcoal and gastric lavage in the prevention of aspirin absorption. J Emerg Med. 1984;1(5):411–416.
   PubMedGoogle Scholar
• Collombel C, Perrot L. Experimental study of the treatment of salicylate poisoning by activated charcoal. Eur J Toxicol. 1970;3(6):352–354.
   PubMedGoogle Scholar
• Eyer F, Jung N, Neuberger H, et al. Enteral exsorption of acetaminophen after intravenous injection in rats: influence of activated charcoal on this clearance path. Basic Clin Pharmacol Toxicol. 2007;101(3):163–171.
   PubMed Web of Science ®Google Scholar
• Ghanem CI, Ruiz ML, Villanueva SSM, et al. Effect of repeated administration with subtoxic doses of acetaminophen to rats on enterohepatic recirculation of a subsequent toxic dose. Biochem Pharmacol. 2009;77(10):1621–1628.
   PubMed Web of Science ®Google Scholar
• el-Sayed YM, Hasan MM. Enhancement of morphine clearance following intravenous administration by oral activated charcoal in rabbits. J Pharm Pharmacol. 1990;42(8):538–541.
   PubMed Web of Science ®Google Scholar
• Midzuaray A, Powell S, Thompson WL, et al. Treatment of poisoning with a new emetic and a new activated-charcoal in dogs. Crit Care Med. 1981;9(3):173.
   Web of Science ®Google Scholar
• Wakabayashi Y, Maruyama S, Hachimura K, et al. Activated charcoal interrupts enteroenteric circulation of phenobarbital. J Toxicol Clin Toxicol. 1994;32(4):419–424.
   PubMed Web of Science ®Google Scholar
• el-Sayed YM, Niazy EM, Tawfik AF, et al. Effect of oral activated charcoal on vancomycin clearance in rabbits with acute renal failure. Drugs Exp Clin Res. 1993;19(1):19–24.
   PubMedGoogle Scholar
• Hasan MM, el-Sayed YM, Abdelaziz AA. The effect of oral activated charcoal on the systemic clearance of gentamicin in rabbits with acute renal failure. J Pharm Pharmacol. 1990;42(2):85–88.
   PubMed Web of Science ®Google Scholar
• Hasan MM, Hassan MA, Rawashdeh NM. Effect of oral activated charcoal on the pharmacokinetics of quinidine and quinine administered intravenously to rabbits. Pharmacol Toxicol. 1990;67(1):73–76.
   PubMedGoogle Scholar
• Ofoefule SI, Onuoha LC, Okonta MJ, et al. Effect of activated charcoal on isoniazid absorption in rabbits. Boll Chim Farm. 2001;140(3):183–186.
   PubMedGoogle Scholar
• Boehm JJ, Brown TC, Oppenheim RC. Reduction of pheniramine toxicity using activated charcoal. Clin Toxicol. 1978;12(5):523–530.
   PubMed Web of Science ®Google Scholar
• Boehm JJ, Brown TCK, Oppenheim RC. Flavoured activated charcoal as an antidote. Australian J Pharm Sci. 1978;7(4):119–121.
   Google Scholar
• McKinney PE, Tomaszewski C, Phillips S, et al. Methamphetamine toxicity prevented by activated charcoal in a mouse model. Ann Emerg Med. 1994;24(2):220–223.
   PubMed Web of Science ®Google Scholar
• Tomaszewski C, McKinney P, Phillips S, et al. Prevention of toxicity from oral cocaine by activated charcoal in mice. Ann Emerg Med. 1993;22(12):1804–1806.
   PubMed Web of Science ®Google Scholar
• Norouzi A, Rajabi R, Rajabalipour F, et al. Comparison of activated charcoal and industrial charcoal in prevention of GI absorption of diazepam. Int J Med Toxicol Forensic Med. 2012;2(4):124–127.
   Google Scholar
• Zhang D, Frost CE, He K, et al. Investigating the enteroenteric recirculation of apixaban, a factor Xa inhibitor: administration of activated charcoal to bile duct-cannulated rats and dogs receiving an intravenous dose and use of drug transporter knockout rats. Drug Metab Dispos. 2013;41(4):906–915.
   PubMed Web of Science ®Google Scholar
• Uzunget SC, Evrin T, Uzunget SB, et al. Evaluation of activated charcoal and lipid emulsion treatment in model of acute rivaroxaban toxicity. Am J Emerg Med. 2018;36(8):1346–1349.
   PubMed Web of Science ®Google Scholar
• Huang JD. Kinetics of theophylline clearance in gastrointestinal dialysis with charcoal. J Pharm Sci. 1987;76(7):525–527.
   PubMed Web of Science ®Google Scholar
• Gades NM, Chyka PA, Butler AY, et al. Activated charcoal and the absorption of ferrous sulfate in rats. Vet Hum Toxicol. 2003;45(4):183–187.
   PubMedGoogle Scholar
• Eshel G, Barr J, Chazan S, et al. Efficacy of orally administered deferoxamine, activated charcoal, and sodium bicarbonate in acute iron intoxication in rats: implications for the treatment of pediatric iron poisoning. Curr Ther Res Clin Exp. 2000;61(9):648–656.
   Web of Science ®Google Scholar
• Yuan L, Wang NN, Dai H, et al. Therapeutic effects of multi-dose activated charcoal on the acute dichlorvos poisoning in rats. Chinese J Emerg Med. 2010;19(6):606–609.
   Google Scholar
• Guven H, Tuncok Y, Gelal A, et al. Prevention of oral dichlorvos toxicity by activated charcoal in mice. Vet Hum Toxicol. 1994;36(4).
   Google Scholar
• Tuncok Y, Gelal A, Apaydin S, et al. Prevention of oral dichlorvos toxicity by different activated charcoal products in mice. Ann Emerg Med. 1995;25(3):353–355.
   PubMed Web of Science ®Google Scholar
• Turnbull GJ. Animal studies on the treatment of poisoning by amitraz (a formamidine pesticide) and xylene. Hum Toxicol. 1983;2(4):579–586.
   PubMedGoogle Scholar
• Cupic V, Dobric S, Milovanovic Z, et al. The efficacy of activated charcoal in protection of animals poisoned with bromadiolone. J Vet Pharmacol Ther. 2003;26(Supplement 1):267.
   Google Scholar
• Wang Z, Yang S, Weng J, et al. Effect of activated carbon on toxicokinetics of methomyl in rat. Lat Am J Pharm. 2016;35(10):2319–2322.
   Web of Science ®Google Scholar
• Wilson KA, Cook RM. Metabolism of xenobiotics in ruminants. Use of activated carbon as an antidote for pesticide poisoning in ruminants. J Agric Food Chem. 1970;18(3):437–440.
   PubMed Web of Science ®Google Scholar
• Guven H, Tuncok Y, Gidener S, et al. In vitro adsorption of dichlorvos and parathion by activated charcoal. J Toxicol Clin Toxicol. 1994;32(2):157–163.
   PubMed Web of Science ®Google Scholar
• Yamashita M, Naito H, Takagi S. The effectiveness of a cation resin (kayexalate) as an adsorbent of paraquat: experimental and clinical studies. Hum Toxicol. 1987;6(1):89–90.
   PubMedGoogle Scholar
• Idid SZ, Lee CY. Effects of fuller's earth and activated charcoal on oral absorption of paraquat in rabbits. Clin Exp Pharmacol Physiol. 1996;23(8):679–681.
   PubMed Web of Science ®Google Scholar
• Kassner JT, Maher TJ, Hull KM, et al. Cholestyramine as an adsorbent in acute lindane poisoning: a murine model. Ann Emerg Med. 1993;22(9):1392–1397.
   PubMed Web of Science ®Google Scholar
• Morgan DP, Dotson TB, Lin LI. Effectiveness of activated charcoal, mineral oil, and castor oil in limiting gastrointestinal absorption of a chlorinated hydrocarbon pesticide. Clin Toxicol. 1977;11(1):61–70.
   PubMed Web of Science ®Google Scholar
• Kovac G, Reichel P, Seidel H, et al. Effects of sorbents during organophosphate intoxication in sheep. Czech J Anim Sci. 1998;43(1):3–7.
   Web of Science ®Google Scholar
• Buck WB, Bratich PM. Activated-charcoal – preventing unnecessary death by poisoning. Vet Med. 1986;81(1):73–77.
   Google Scholar
• Hunder G, Fichtl B, Forth W. Influence of glucocorticoids and activated charcoal on the lethality of rats after acute poisoning with T-2 toxin, diacetoxyscirpenol, or roridin A. Nat Toxins. 1994;2(3):120–123.
   PubMedGoogle Scholar
• Devreese M, Antonissen G, De Backer P, et al. Efficacy of active carbon towards the absorption of deoxynivalenol in pigs. Toxins. 2014;6(10):2998–3004.
   PubMed Web of Science ®Google Scholar
• Qualls HJ, Holbrook TC, Gilliam LL, et al. Evaluation of efficacy of mineral oil, charcoal, and smectite in a rat model of equine cantharidin toxicosis. J Vet Intern Med. 2013;27(5):1179–1184.
   PubMed Web of Science ®Google Scholar
• Lambert RJ, Kindler BL, Schaeffer DJ. The efficacy of superactivated charcoal in treating rats exposed to a lethal oral dose of potassium cyanide. Ann Emerg Med. 1988;17(6):595–598.
   PubMed Web of Science ®Google Scholar
• Zhang HS, Zhou J, Zhang SL, et al. Toxicokinetics of tetramethylene disulphotetramine. Chinese J Preventive Med. 2005;39(2):91–94.
   Google Scholar
• Lehmann PA, Favari L. Acute thallium intoxication: kinetic study of the relative efficacy of several antidotal treatments in rats. Arch Toxicol. 1985;57(1):56–60.
   PubMed Web of Science ®Google Scholar
• Al-Mahasneh QM, Rodgers GC, Benz FW. Activated charcoal Ac as an adsorbent for inorganic arsenic study in rats. Vet Hum Toxicol. 1990;32(4):14–18.
   Google Scholar
• Veenendaal EM. Arsenic antidote versus charcoal therapy in arsenic poisoning. Ned Tijdschr Geneeskd. 1951;95(47):3481–3484.
   PubMedGoogle Scholar
• Dean BS, Burdick JD, Geotz CM, et al. In vivo evaluation of the adsorptive capacity of activated charcoal for camphor. Vet Hum Toxicol. 1992;34(4):297–300.
   PubMedGoogle Scholar
• Floersheim GL. Rifampicin and cysteamine protect against the mushroom toxin phalloidin. Experientia. 1974;30(11):1310–1312.
   PubMedGoogle Scholar
• Ozmaie S. The effect of propranolol hydrochloride and activated charcoal in treatment of experimental oleander (nerium oleander) poisoning in sheep. Toxicol Lett. 2011;205:S91.
   Web of Science ®Google Scholar
• Lipscomb DJ, Widdop B. Studies with activated charcoal in the treatment of drug overdosage using the pig as an animal model. Arch Toxicol. 1975;34(1):37–46.
   PubMed Web of Science ®Google Scholar
• Picchioni AL, Chin L, Duplisse BR. Comparison of activated charcoal Arizona montmorillonite and evaporated milk as antidotes in poisoning. Fed Proc. 1968;27(2):465.
   Google Scholar
• Fiser RH, Maetz HM, Treuting JJ, et al. Activated charcoal in barbiturate and glutethimide poisoning of the dog. J Pediatr. 1971;78(6):1045–1047.
   PubMed Web of Science ®Google Scholar
• Chin L, Picchioni AL, Bourn WM, et al. Optimal antidotal dose of activated charcoal. Toxicol Appl Pharmacol. 1973;26(1):103–108.
   PubMed Web of Science ®Google Scholar
• Blackett T, Bates N. Humulus lupulus (hops) ingestion in 13 domestic dogs. Clin Toxicol. 2019;57(6):527–528.
   Web of Science ®Google Scholar
• Furr AA, Carson TL. Therapeutic measures used in the treatment of organophosphorus insecticide toxicosis in sheep. Vet Toxicol. 1975;17(4):121–122.
   Google Scholar
• Anastasio JD, Sharp CR. Acute aldicarb toxicity in dogs: 15 cases (2001-2009). J Vet Emerg Crit Care. 2011;21(3):253–260.
   PubMed Web of Science ®Google Scholar
• Bates MC, Roady P, Lehner AF, et al. Atypical bromethalin intoxication in a dog: pathologic features and identification of an isomeric breakdown product. BMC Vet Res. 2015;11:244.
   PubMed Web of Science ®Google Scholar
• Bates N, Crouchley J, Edwards N. Electronic cigarette ingestion in dogs. Clin Toxicol. 2015;53(4):276.
   Web of Science ®Google Scholar
• Beal MW, Poppenga RH, Birdsall WJ, et al. Respiratory failure attributable to moxidectin intoxication in a dog. J Am Vet Med Assoc. 1999;215(12):1813–1817.
   PubMed Web of Science ®Google Scholar
• Markel MD, Dyer RM, Hattel AL. Acute renal failure associated with application of a mercuric blister in a horse. J Am Vet Med Assoc. 1984;185(1):92–94.
   PubMed Web of Science ®Google Scholar
• Johnson D, Eppler J, Giesbrecht E, et al. Effect of multiple-dose activated charcoal on the clearance of high-dose intravenous aspirin in a porcine model. Ann Emerg Med. 1995;26(5):569–574.
   PubMed Web of Science ®Google Scholar
• Wogan J, Frommer D, Kulig K, et al. Multiple dose activated-charcoal for intravenous salicylate intoxication in a dog-model. Vet Hum Toxicol. 1987;29:41.
   PubMedGoogle Scholar
• Wogan JM, Kulig K, Frommer DA. Multiple-dose activated charcoal in salicylate poisoning. Ann Emerg Med. 1986;15(5):202.
   PubMedGoogle Scholar
• Douidar SM, Hale TW, Trevino D, et al. The effect of multiple dose activated charcoal MDAC on the elimination of intravenous IV sodium salicylate in rabbits. Vet Hum Toxicol. 1992;34(4):362.
   Google Scholar
• Eppler J, Johnson D, Giesbrecht E, et al. Effect of multi-dose activated charcoal on the clearance of high dose intravenous aspirin in pigs. Vet Hum Toxicol. 1994;36(4):347.
   Google Scholar
• Guentert TW, Schmitt M, Defoin R. Acceleration of the elimination of tenoxicam by cholestyramine in the dog. J Pharmacol Exp Ther. 1986;238(1):295–301.
   PubMed Web of Science ®Google Scholar
• Siegers CP, Rozman K, Klaassen CD. Biliary excretion and entero hepatic circulation of paracetamol in the rat. Xenobiotica. 1983;13(10):591–596.
   PubMed Web of Science ®Google Scholar
• Zajtchuk R, Corby DG, Miller JG, et al. Treatment of digoxin toxicity with activated-charcoal. Am J Cardiol. 1975;35(1):178.
   Web of Science ®Google Scholar
• Caldwell JH, Caldwell PB, Murphy JW, et al. Intestinal secretion of digoxin in the rat. Augmentation by feeding activated charcoal. Naunyn Schmiedebergs Arch Pharmacol. 1980;312(3):271–275.
   PubMed Web of Science ®Google Scholar
• Arimori K, Nakano M. Transport of procainamide and N-acetylprocainamide from blood into the intestinal lumen and intestinal dialysis by oral activated charcoal in rats with acute renal failure. J Pharmacobiodyn. 1988;11(7):504–511.
   PubMedGoogle Scholar
• Arimori K, Nakano M. The intestinal dialysis of intravenously administered phenytoin by oral activated charcoal in rats. J Pharmacobiodyn. 1987;10(4):157–165.
   PubMedGoogle Scholar
• Edwards DM, Feely J. A model to study enhanced drug elimination during repeated dosing with activated charcoal. Br J Pharmacol. 1984;81(SUPPL).
   Google Scholar
• Laine K, Kivisto KT, Neuvonen PJ. Failure of oral activated charcoal to accelerate the elimination of amiodarone and chloroquine. Hum Exp Toxicol. 1992;11(6):491–494.
   PubMed Web of Science ®Google Scholar
• Arimori K, Nakano M. Dose-dependency in the exsorption of theophylline and the intestinal dialysis of theophylline by oral activated charcoal in rats. J Pharm Pharmacol. 1988;40(2):101–105.
   PubMed Web of Science ®Google Scholar
• Brashear RE, Aronoff GR, Brier RA. Activated charcoal in theophylline intoxication. J Lab Clin Med. 1985;106(3):242–245.
   PubMed Web of Science ®Google Scholar
• McKinnon RS, Desmond PV, Harman PJ, et al. Studies on the mechanisms of action of activated charcoal on theophylline pharmacokinetics. J Pharm Pharmacol. 1987;39(7):522–525.
   PubMed Web of Science ®Google Scholar
• Arimori K, Wakayama K, Nakano M. Increased transport of theophylline into gastrointestinal lumen and gastrointestinal dialysis by activated charcoal in rats with hepatic cirrhosis. Chem Pharm Bull. 1989;37(11):3148–3149.
   PubMed Web of Science ®Google Scholar
• Kulig KW, Bar-Or D, Rumack BH. Intravenous theophylline poisoning and multiple-dose charcoal in an animal-model. Ann Emerg Med. 1987;16(8):842–846.
   PubMed Web of Science ®Google Scholar
• Kulig K, Baror D, Rumack BH. Intravenous aminophylline overdose – enhanced elimination by gastrointestinal activated-charcoal in experimental-animals. Vet Hum Toxicol. 1983;25(4):269.
   Google Scholar
• Arimori K, Nakano M. Accelerated clearance of intravenously administered theophylline and phenobarbital by oral doses of activated charcoal in rats. A possibility of the intestinal dialysis. J Pharmacobiodyn. 1986;9(5):437–441.
   PubMedGoogle Scholar
• Balram C, Zhou QY, Cheung YB, et al. Influence of multiple dose activated charcoal on the disposition kinetics of irinotecan in rats. Drug Metabol Drug Interact. 2002;19(2):137–148.
   PubMedGoogle Scholar
• Michiels M, Monbaliu J, Hendriks R, et al. Pharmacokinetics and tissue distribution of the new gastrokinetic agent cisapride in rat, rabbit and dog. Arzneimittelforschung. 1987;37(10):1159–1167.
   PubMed Web of Science ®Google Scholar
• Offor SJ, Mbagwu HO, Orisakwe OE. Lead induced hepato-renal damage in male albino rats and effects of activated charcoal. Front Pharmacol. 2017;8:107.
   PubMed Web of Science ®Google Scholar
• Leloux MS, Nguyen PL, Claude JR. Experimental studies on thallium toxicity in rats. II--the influence of several antidotal treatments on the tissue distribution and elimination of thallium, after subacute intoxication. J Toxicol Clin Exp. 1990;10(3):147–156.
   PubMedGoogle Scholar
• Kobel W, Sumner DD, Campbell JB, et al. Protective effect of activated charcoal in cattle poisoned with atrazine. Vet Hum Toxicol. 1985;27(3):185–188.
   PubMedGoogle Scholar
• Mathangi DC, Devi RS, Namasivayam A. Activated charcoal--an antidote to methyl alcohol poisoning. J Indian Med Assoc. 1995;93(4):136–137.
   PubMedGoogle Scholar
• Chyka PA, Holley JE, Mandrell TD, et al. Correlation of drug pharmacokinetics and effectiveness of multiple-dose activated charcoal therapy. Ann Emerg Med. 1995;25(3):356–362.
   PubMed Web of Science ®Google Scholar
• Adler LJ, Waters DH, Gwilt PR. The effect of activated charcoal on mouse sleep times induced by intravenously administered hypnotics. Biopharm Drug Dispos. 1986;7(5):421–429.
   PubMed Web of Science ®Google Scholar
• Fransson BA, Mealey KA, Dutta SR. Clozapine intoxication in a dog. J Am Anim Hosp Assoc. 2002;38(5):421–424.
   PubMed Web of Science ®Google Scholar
• Mariani PJ, Pook N. Gastrointestinal tract perforation with charcoal peritoneum complicating orogastric intubation and lavage. Ann Emerg Med. 1993;22(3):606–609.
   PubMed Web of Science ®Google Scholar
• McKinney PE, Phillips S, Gomez HF, et al. Corneal abrasions secondary to activated charcoal. Am J Emerg Med. 1993;11(5):562.
   PubMed Web of Science ®Google Scholar
• Merriman T, Stokes K. Small bowel obstruction secondary to administration of activated charcoal. Aust N Z J Surg. 1995;65(4):288–289.
   PubMedGoogle Scholar
• Moore EW, Davies MW. A black hole: an unexpected cause of difficult intubation. Anaesthesia. 1996;51(8):795–796.
   PubMed Web of Science ®Google Scholar
• Nobre LF, Marchiori E, Carrao AD, et al. Pulmonary instillation of activated charcoal: early findings on computed tomography. Ann Thorac Surg. 2011;91(2):642–643.
   PubMed Web of Science ®Google Scholar
• Mirakbari SM. Hot charcoal vomitus in aluminum phosphide poisoning – a case report of internal thermal reaction in aluminum phosphide poisoning and review of literature. Indian J Anaesth. 2015;59(7):433–436.
   PubMed Web of Science ®Google Scholar
• Toledo AS, Cabral ERM, Vieira RJ, et al. Activated charcoal pulmonary aspiration as complication from an inappropriate treatment of a patient with previous bariatric surgery after aldicarb (chumbinho) poisoning. Clin Toxicol. 2012;50(4):330.
   Web of Science ®Google Scholar
• Rajamani S, Allen P. Accidental charcoal aspiration. J Bronchol. 2004;11(2):130–131.
   Google Scholar
• Ubaidat M, Johnson GF, Feld RD. Increased propylene glycol levels following treatment with activated charcoal. Clin Chem. 2001;47(S6):A70.
   Google Scholar
• Wallace DE. Bowel ischemia in two patients following tricyclic antidepressant (TCA) overdose. Vet Hum Toxicol. 1989;31(4):377.
   Google Scholar
• Woolf AD, Gren J. Hypermagnesemia associated with catharsis in a salicylate intoxicated patient with anorexia nervosa. Vet Hum Toxicol. 1988;30(4):352.
   Google Scholar
• Doneray H, Orbak Z, Karakelleoglu C. Clinical outcomes in children with hyoscyamus niger intoxication not receiving physostigmine therapy. Eur J Emerg Med. 2007;14(6):348–350.
   PubMed Web of Science ®Google Scholar
• Seder DB, Christman RA, Quinn MO, et al. A 45-year-old man with a lung mass and history of charcoal aspiration. Respir Care. 2006;51(11):1251–1254.
   PubMed Web of Science ®Google Scholar
• Silberman H, Davis SM, Lee A. Activated charcoal aspiration. N C Med J. 1990;51(2):79–80.
   PubMedGoogle Scholar
• Strobel J, Zimmermann R, Eckstein R, et al. Charcoal intake and oral anticoagulation. J Travel Med. 2010;17(4):287–288.
   PubMed Web of Science ®Google Scholar
• Tenenbein M, Shirota K, Pasterkamp H. Activated charcoal aspiration produces direct pulmonary injury. J Toxicol Clin Toxicol. 1999;37(5):598.
   Google Scholar
• Anonymous. Toxicity of sorbitol-charcoal suspension. J Pediatr. 1987;111(2):307–308.
   Google Scholar
• Graff GR, Stark J, Berkenbosch JW, et al. Chronic lung disease after activated charcoal aspiration. Pediatrics. 2002;109(5):959–961.
   PubMed Web of Science ®Google Scholar
• Gomez HF, Brent JA, Munoz DCt, et al. Charcoal stercolith with intestinal perforation in a patient treated for amitriptyline ingestion. J Emerg Med. 1994;12(1):57–60.
   PubMedGoogle Scholar
• Atkinson SW, Young Y, Trotter GA. Treatment with activated charcoal complicated by gastrointestinal obstruction requiring surgery. BMJ. 1992;305(6853):563.
   PubMedGoogle Scholar
• Bairral BQ, Saito M, Morrone N. Activated charcoal bronchial aspiration. J Bras Pneumol. 2012;38(4):533–534.
   PubMed Web of Science ®Google Scholar
• Essig LW, Allen JN. Respiratory failure and refractory hypoxemia due to activated charcoal aspiration: treatment with bronchoscopic surfactant administration. Chest. 2005;128(4):479S.
   PubMed Web of Science ®Google Scholar
• Francis RC, Schefold JC, Bercker S, et al. Acute respiratory failure after aspiration of activated charcoal with recurrent deposition and release from an intrapulmonary cavern. Intensive Care Med. 2009;35(2):360–363.
   PubMed Web of Science ®Google Scholar
• Garrelts JC, Watson WA, Holloway KD, et al. Magnesium toxicity secondary to catharsis during management of theophylline poisoning. Am J Emerg Med. 1989;7(1):34–37.
   PubMed Web of Science ®Google Scholar
• Gatselis NK, Liamis G, Makaritsis KP, et al. Metabolic acidosis during treatment of mushroom poisoning: a diagnostic pitfall. Intern Med. 2012;51(9):1077–1080.
   PubMed Web of Science ®Google Scholar
• Gerard SK, Hernandez C, Khayam Bashi H. Extreme hypermagnesemia caused by an overdose of magnesium-containing cathartics. Ann Emerg Med. 1988;17(7):728–731.
   PubMed Web of Science ®Google Scholar
• Givens T, Holloway M, Wason S. Pulmonary aspiration of activated charcoal: a complication of its misuse in overdose management. Pediatr Emerg Care. 1992;8(3):137–140.
   PubMed Web of Science ®Google Scholar
• Godambe SA, Mack JW, Chung DS, et al. Iatrogenic pleuropulmonary charcoal instillation in a teenager. Pediatr Pulmonol. 2003;35(6):490–493.
   PubMed Web of Science ®Google Scholar
• Golej J, Boigner H, Burda G, et al. Severe respiratory failure following charcoal application in a toddler. Resuscitation. 2001;49(3):315–318.
   PubMed Web of Science ®Google Scholar
• Gren J, Woolf A. Hypermagnesemia associated with catharsis in a salicylate-intoxicated patient with anorexia nervosa. Ann Emerg Med. 1989;18(2):200–203.
   PubMed Web of Science ®Google Scholar
• Gazda-Smith E, Synhavsky A. Hypernatremia following treatment of theophylline toxicity with activated charcoal and sorbitol. Arch Intern Med. 1990;150(3):689–692.
   PubMedGoogle Scholar
• Kim SY, Koo JS, Hynun JJ, et al. Charcoal-induced pseudomelanosis ilei. Endoscopy. 2011;43(S02):E380.
   PubMedGoogle Scholar
• Chan JC, Saranasuriya C, Waxman BP. Bezoar causing small bowel obstruction after repeated activated charcoal administration. Med J Aust. 2005;183(10):537.
   PubMed Web of Science ®Google Scholar
• Eroglu A, Kucuktulu U, Erciyes N, et al. Multiple dose-activated charcoal as a cause of acute appendicitis. J Toxicol Clin Toxicol. 2003;41(1):71–73.
   PubMed Web of Science ®Google Scholar
• Crispen C, Kempf J, Greydanus DE. Intussusception as a possible complication of organophospate overdose and/or treatment. Clin Pediatr. 1985;24(3):140.
   Web of Science ®Google Scholar
• Critchley JA, Critchley LA. Digoxin toxicity in chronic renal failure: treatment by multiple dose activated charcoal intestinal dialysis. Hum Exp Toxicol. 1997;16(12):733–735.
   PubMed Web of Science ®Google Scholar
• Papierniak ES, Suarez J, Jantz M. Chronic restrictive lung disease secondary to aspiration of activated charcoal. American Journal of Respiratory and Crit Care Med Conference: American Thoracic Society International Conference, ATS. 2015;191.
   Google Scholar
• Kyan R, Uemura S, Tanno K, et al. Severe accidental colchicine poisoning by the autumn crocus: a case of successful treatment. J Acute Med. 2015;5(4):103–106.
   Web of Science ®Google Scholar
• Aljohani TK, Alshamrani AM, Alzahrani AM, et al. A rare case of small bowel obstruction secondary to activated charcoal administration. J Surg Case Rep. 2019;2019(2):rjz033.
   PubMedGoogle Scholar
• Allerton JP, Strom JA. Hypernatremia due to repeated doses of charcoal-sorbitol. Am J Kidney Dis. 1991;17(5):581–584.
   PubMed Web of Science ®Google Scholar
• Arnold TC, Willis BH, Xiao F, et al. Aspiration of activated charcoal elicits an increase in lung microvascular permeability. J Toxicol Clin Toxicol. 1999;37(1):9–16.
   PubMed Web of Science ®Google Scholar
• Arnold TC, Zhang S, Xiao F, et al. Pressure-controlled ventilation attenuates lung microvascular injury in a rat model of activated charcoal aspiration. J Toxicol Clin Toxicol. 2003;41(2):119–124.
   PubMed Web of Science ®Google Scholar
• Adams BK, Mann MD, Aboo A, et al. The effects of sorbitol on gastric emptying half-times and small intestinal transit after drug overdose. Am J Emerg Med. 2006;24(1):130–132.
   PubMed Web of Science ®Google Scholar
• Jurgens G, Hoegberg LC, Graudal NA. The effect of activated charcoal on drug exposure in healthy volunteers: a meta-analysis. Clin Pharmacol Ther. 2009;85(5):501–505.
   PubMed Web of Science ®Google Scholar
• World Health Organization Pharmacopoeia. Charcoal, activated. Geneva: WHO; 2019. [cited 2019 Feb 20]. Available from: https://www.who.int/medicines/publications/pharmacopoeia/en/.
   Google Scholar